Biocryst Pharmaceuticals Inc.. (BCRX) NASDAQ
$6.15 0.27 (4.59%)
Market Cap: $1.26B
As of 12/01/23 04:00 PM EST. Market closed.

Biocryst Pharmaceuticals Inc.. (BCRX)
NASDAQ
$6.15
0.27 (4.59%)
Market Cap: $1.26B
As of 12/01/23 04:00 PM EST. Market closed.
biocryst pharmaceuticals, a biotechnology company, designs, optimizes and develops novel small-molecule drugs that block key enzymes involved in infectious and rare diseases. founded in 1986, biocryst has more than 50 employees and is experiencing continued growth. the company’s headquarters are located in research triangle park, north carolina and its discovery center of excellence is in ... read more
biocryst pharmaceuticals, a biotechnology company, designs, optimizes and develops novel small-molecule drugs that block key enzymes involved in infectious and rare diseases. founded in 1986, biocryst has more than 50 employees and is experiencing continued growth. the company’s headquarters are located in research triangle park, north carolina and its discovery center of excellence is in birmingham, alabama. with expertise in drug discovery, clinical development, regulatory affairs and product commercialization, we continue to advance our clinical programs and to generate new compounds from our own discovery engine. we are proud of our culture of engagement and accountability that rewards people for innovative thinking and achievement of key objectives. the commitment of biocryst remains unchanged. we continue to be passionate about developing and marketing novel therapeutics for patients with rare and serious diseases. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
MILANO VINCENT | Director | Nov 30, 2023 | Option Exercise | $5.88 | 956 | 5,621 | 50,998 | Dec 01, 2023, 04:42 PM |
HEGGIE THERESA | Director | Nov 30, 2023 | Option Exercise | $5.88 | 956 | 5,621 | 50,861 | Dec 01, 2023, 04:40 PM |
MILANO VINCENT | Director | Aug 31, 2023 | Option Exercise | $7.11 | 791 | 5,624 | 50,042 | Sep 05, 2023, 04:43 PM |
HEGGIE THERESA | Director | Aug 31, 2023 | Option Exercise | $7.11 | 791 | 5,624 | 49,905 | Sep 05, 2023, 04:41 PM |
SANDERS MACHELLE | Director | Jun 15, 2023 | Sale | $7.98 | 4,000 | 31,920 | 25,611 | Jun 15, 2023, 04:37 PM |
Hutson Nancy J | Director | Jun 14, 2023 | Sale | $8.04 | 12,866 | 103,443 | 81,818 | Jun 15, 2023, 04:33 PM |
MILANO VINCENT | Director | May 31, 2023 | Option Exercise | $8.27 | 680 | 5,624 | 32,506 | Jun 02, 2023, 04:36 PM |
LEVIN ALAN G | Director | May 31, 2023 | Option Exercise | $8.27 | 1,360 | 11,247 | 20,345 | Jun 02, 2023, 04:34 PM |
HEGGIE THERESA | Director | May 31, 2023 | Option Exercise | $8.27 | 680 | 5,624 | 32,369 | Jun 02, 2023, 04:32 PM |
Thackray Helen M. | Chief R&D Officer | Apr 03, 2023 | Sale | $8.29 | 7,000 | 58,030 | 207,275 | Apr 05, 2023, 04:33 PM |
Stonehouse Jon P | President & CEO | Mar 21, 2023 | Option Exercise | $3.22 | 31,055 | 99,997 | 1,039,794 | Mar 23, 2023, 04:40 PM |
MILANO VINCENT | Director | Feb 28, 2023 | Option Exercise | $8.85 | 635 | 5,620 | 31,826 | Mar 02, 2023, 04:44 PM |
INGRAM ROBERT ALEXANDER | Director | Feb 28, 2023 | Option Exercise | $8.85 | 2,259 | 19,992 | 100,198 | Mar 02, 2023, 04:41 PM |
Stonehouse Jon P | President & CEO | Feb 01, 2023 | Option Exercise | $5.45 | 100,000 | 545,000 | 1,108,739 | Feb 02, 2023, 05:20 PM |
Stonehouse Jon P | President & CEO | Feb 01, 2023 | Sale | $10.38 | 100,000 | 1,038,000 | 1,008,739 | Feb 02, 2023, 05:20 PM |
LEE KENNETH B JR | Director | Jan 31, 2023 | Option Exercise | $1.71 | 15,000 | 25,650 | 52,118 | Feb 02, 2023, 05:15 PM |
Stonehouse Jon P | President & CEO | Dec 15, 2022 | Sale | $10.90 | 14,100 | 153,690 | 887,730 | Dec 19, 2022, 05:09 PM |
Thackray Helen M. | Chief R&D Officer | Dec 15, 2022 | Sale | $10.89 | 3,125 | 34,031 | 133,275 | Dec 19, 2022, 04:58 PM |
Doyle Anthony | Chief Financial Officer | Dec 15, 2022 | Sale | $10.90 | 5,700 | 62,130 | 163,966 | Dec 19, 2022, 04:55 PM |
Gayer Charles K | Chief Commercial Officer | Dec 15, 2022 | Sale | $10.90 | 6,100 | 66,490 | 211,610 | Dec 19, 2022, 04:48 PM |
Jones Michael L | Exec. Director, Finance - PAO | Dec 15, 2022 | Sale | $10.90 | 445 | 4,850 | 10,753 | Dec 19, 2022, 04:45 PM |
Barnes Alane P | Chief Legal Officer | Dec 15, 2022 | Sale | $10.88 | 4,175 | 45,424 | 198,770 | Dec 19, 2022, 04:38 PM |
Jones Michael L | Exec. Director, Finance - PAO | Dec 01, 2022 | Option Exercise | $1.42 | 8,600 | 12,212 | 19,798 | Dec 02, 2022, 06:36 PM |
Jones Michael L | Exec. Director, Finance - PAO | Dec 01, 2022 | Sale | $13.01 | 8,600 | 111,886 | 11,198 | Dec 02, 2022, 06:36 PM |
Stonehouse Jon P | President & CEO | Dec 02, 2022 | Option Exercise | $1.42 | 82,656 | 117,372 | 984,486 | Dec 02, 2022, 06:33 PM |
Stonehouse Jon P | President & CEO | Dec 01, 2022 | Option Exercise | $1.42 | 214,917 | 305,182 | 1,116,747 | Dec 02, 2022, 06:33 PM |
Stonehouse Jon P | President & CEO | Dec 02, 2022 | Sale | $12.80 | 82,656 | 1,057,997 | 901,830 | Dec 02, 2022, 06:33 PM |
Stonehouse Jon P | President & CEO | Dec 01, 2022 | Sale | $13.00 | 214,917 | 2,793,921 | 901,830 | Dec 02, 2022, 06:33 PM |
HEGGIE THERESA | Director | Nov 30, 2022 | Option Exercise | $13.36 | 421 | 5,625 | 31,054 | Dec 02, 2022, 06:30 PM |
MILANO VINCENT | Director | Nov 30, 2022 | Option Exercise | $13.36 | 421 | 5,625 | 31,191 | Dec 02, 2022, 06:28 PM |
LEVIN ALAN G | Director | Nov 30, 2022 | Option Exercise | $13.36 | 842 | 11,249 | 17,714 | Dec 02, 2022, 06:26 PM |
INGRAM ROBERT ALEXANDER | Director | Nov 30, 2022 | Option Exercise | $13.36 | 1,497 | 20,000 | 97,939 | Dec 02, 2022, 06:24 PM |
Babu Yarlagadda S | Chief Discovery Officer | Nov 14, 2022 | Option Exercise | $1.42 | 100,000 | 142,000 | 330,056 | Nov 16, 2022, 04:19 PM |
Babu Yarlagadda S | Chief Discovery Officer | Nov 14, 2022 | Sale | $13.88 | 31,515 | 437,428 | 298,541 | Nov 16, 2022, 04:19 PM |
MILANO VINCENT | Director | Aug 31, 2022 | Option Exercise | $13.90 | 404 | 5,616 | 30,770 | Sep 02, 2022, 04:36 PM |
LEVIN ALAN G | Director | Aug 31, 2022 | Option Exercise | $13.90 | 809 | 11,245 | 16,872 | Sep 02, 2022, 04:34 PM |
INGRAM ROBERT ALEXANDER | Director | Aug 31, 2022 | Option Exercise | $13.90 | 1,438 | 19,988 | 96,442 | Sep 02, 2022, 04:31 PM |
HEGGIE THERESA | Director | Aug 31, 2022 | Option Exercise | $13.90 | 404 | 5,616 | 30,633 | Sep 02, 2022, 04:29 PM |
ASELAGE STEVE | Director | May 31, 2022 | Option Exercise | $9.31 | 569 | 5,297 | 33,728 | Jun 02, 2022, 04:43 PM |
HEGGIE THERESA | Director | May 31, 2022 | Option Exercise | $9.31 | 1,138 | 10,595 | 17,363 | Jun 02, 2022, 04:40 PM |
LEVIN ALAN G | Director | May 31, 2022 | Option Exercise | $9.31 | 1,138 | 10,595 | 3,197 | Jun 02, 2022, 04:37 PM |
INGRAM ROBERT ALEXANDER | Director | May 31, 2022 | Option Exercise | $9.31 | 2,078 | 19,346 | 82,138 | Jun 02, 2022, 04:34 PM |
ABERCROMBIE GEORGE B | Director | Apr 18, 2022 | Option Exercise | $3.32 | 5,000 | 16,600 | 5,000 | Apr 20, 2022, 04:23 PM |
ABERCROMBIE GEORGE B | Director | Apr 18, 2022 | Sale | $11.04 | 5,000 | 55,200 | 0 | Apr 20, 2022, 04:23 PM |
Thackray Helen M. | Chief R&D Officer | Apr 01, 2022 | Sale | $16.20 | 7,600 | 123,120 | 136,400 | Apr 04, 2022, 04:32 PM |
Sheridan William P | Chief Medical Officer | Mar 10, 2022 | Option Exercise | $3.22 | 148,302 | 477,532 | 199,093 | Mar 14, 2022, 04:21 PM |
Sheridan William P | Chief Medical Officer | Mar 10, 2022 | Sale | $16.88 | 161,139 | 2,719,493 | 39,354 | Mar 14, 2022, 04:21 PM |
Babu Yarlagadda S | Chief Discovery Officer | Mar 07, 2022 | Sale | $17.16 | 20,000 | 343,200 | 230,056 | Mar 09, 2022, 04:24 PM |
Jones Michael L | Exec. Director, Finance - PAO | Mar 01, 2022 | Option Exercise | $4.73 | 2,300 | 10,879 | 13,498 | Mar 03, 2022, 05:04 PM |
Jones Michael L | Exec. Director, Finance - PAO | Mar 01, 2022 | Sale | $17.20 | 2,300 | 39,560 | 11,198 | Mar 03, 2022, 05:04 PM |
LEVIN ALAN G | Director | Feb 28, 2022 | Option Exercise | $16.61 | 602 | 9,999 | 2,059 | Mar 02, 2022, 04:43 PM |
INGRAM ROBERT ALEXANDER | Director | Feb 28, 2022 | Option Exercise | $16.61 | 1,128 | 18,736 | 80,060 | Mar 02, 2022, 04:40 PM |
ABERCROMBIE GEORGE B | Director | Feb 15, 2022 | Option Exercise | $3.32 | 5,000 | 16,600 | 5,000 | Feb 16, 2022, 04:25 PM |
ABERCROMBIE GEORGE B | Director | Feb 15, 2022 | Sale | $18.50 | 5,000 | 92,500 | 0 | Feb 16, 2022, 04:25 PM |
Stonehouse Jon P | President & CEO | Jan 11, 2022 | Option Exercise | $4.73 | 184,000 | 870,320 | 1,085,602 | Jan 13, 2022, 04:45 PM |
Stonehouse Jon P | President & CEO | Jan 11, 2022 | Sale | $15.04 | 184,000 | 2,767,360 | 901,602 | Jan 13, 2022, 04:45 PM |
Babu Yarlagadda S | Chief Discovery Officer | Dec 07, 2021 | Option Exercise | $4.73 | 62,000 | 293,260 | 245,156 | Dec 09, 2021, 04:38 PM |
Babu Yarlagadda S | Chief Discovery Officer | Dec 07, 2021 | Sale | $12.20 | 30,100 | 367,220 | 215,056 | Dec 09, 2021, 04:38 PM |
ASELAGE STEVE | Director | Nov 30, 2021 | Option Exercise | $12.06 | 414 | 4,993 | 32,858 | Dec 02, 2021, 04:15 PM |
LEVIN ALAN G | Director | Nov 30, 2021 | Option Exercise | $12.06 | 829 | 9,998 | 1,457 | Dec 02, 2021, 04:13 PM |
HEGGIE THERESA | Director | Nov 30, 2021 | Option Exercise | $12.06 | 829 | 9,998 | 15,623 | Dec 02, 2021, 04:10 PM |
INGRAM ROBERT ALEXANDER | Director | Nov 30, 2021 | Option Exercise | $12.06 | 1,554 | 18,741 | 78,932 | Dec 02, 2021, 04:08 PM |
MILANO VINCENT | Director | Nov 24, 2021 | Buy | $12.19 | 7,500 | 91,425 | 17,500 | Nov 24, 2021, 06:35 PM |
Doyle Anthony | Chief Financial Officer | Nov 23, 2021 | Buy | $12.48 | 35,258 | 440,020 | 93,719 | Nov 24, 2021, 06:35 PM |
ABERCROMBIE GEORGE B | Director | Nov 15, 2021 | Option Exercise | $3.32 | 5,000 | 16,600 | 5,000 | Nov 17, 2021, 04:27 PM |
ABERCROMBIE GEORGE B | Director | Nov 15, 2021 | Sale | $12.27 | 5,000 | 61,350 | 0 | Nov 17, 2021, 04:27 PM |
Hutson Nancy J | Director | Oct 15, 2021 | Option Exercise | $3.46 | 105,000 | 363,450 | 170,073 | Oct 19, 2021, 04:21 PM |
Hutson Nancy J | Director | Oct 15, 2021 | Sale | $15.40 | 105,000 | 1,617,000 | 65,073 | Oct 19, 2021, 04:21 PM |
ABERCROMBIE GEORGE B | Director | Sep 15, 2021 | Option Exercise | $2.63 | 5,000 | 13,150 | 5,000 | Sep 17, 2021, 04:31 PM |
ABERCROMBIE GEORGE B | Director | Sep 15, 2021 | Sale | $15.06 | 5,000 | 75,300 | 0 | Sep 17, 2021, 04:31 PM |
LEE KENNETH B JR | Director | Sep 13, 2021 | Option Exercise | $3.22 | 15,000 | 48,300 | 30,252 | Sep 15, 2021, 04:26 PM |
LEE KENNETH B JR | Director | Sep 13, 2021 | Sale | $15.35 | 6,000 | 92,100 | 24,252 | Sep 15, 2021, 04:26 PM |
ABERCROMBIE GEORGE B | Director | Sep 10, 2021 | Option Exercise | $2.86 | 71,000 | 202,710 | 74,000 | Sep 14, 2021, 04:14 PM |
ABERCROMBIE GEORGE B | Director | Sep 10, 2021 | Sale | $15.09 | 74,000 | 1,116,660 | 0 | Sep 14, 2021, 04:14 PM |
LEVIN ALAN G | Director | Aug 31, 2021 | Option Exercise | $15.92 | 628 | 9,998 | 628 | Sep 02, 2021, 04:36 PM |
INGRAM ROBERT ALEXANDER | Director | Aug 31, 2021 | Option Exercise | $15.92 | 1,177 | 18,738 | 77,378 | Sep 02, 2021, 04:33 PM |
HEGGIE THERESA | Director | Aug 31, 2021 | Option Exercise | $15.92 | 628 | 9,998 | 14,794 | Sep 02, 2021, 04:30 PM |
ASELAGE STEVE | Director | Aug 31, 2021 | Option Exercise | $15.92 | 314 | 4,999 | 32,444 | Sep 02, 2021, 04:28 PM |
ABERCROMBIE GEORGE B | Director | Jul 15, 2021 | Option Exercise | $2.63 | 5,000 | 13,150 | 8,000 | Jul 19, 2021, 04:39 PM |
ABERCROMBIE GEORGE B | Director | Jul 15, 2021 | Sale | $15.69 | 5,000 | 78,450 | 3,000 | Jul 19, 2021, 04:39 PM |
Hutson Nancy J | Director | May 28, 2021 | Option Exercise | $15.77 | 317 | 4,999 | 65,073 | Jun 01, 2021, 04:24 PM |
ASELAGE STEVE | Director | May 28, 2021 | Option Exercise | $15.77 | 634 | 9,998 | 32,130 | Jun 01, 2021, 04:16 PM |
Barnes Alane P | Chief Legal Officer | May 12, 2021 | Option Exercise | $4.73 | 35,852 | 169,580 | 146,127 | May 13, 2021, 04:43 PM |
Barnes Alane P | Chief Legal Officer | May 11, 2021 | Option Exercise | $4.14 | 102,780 | 425,442 | 213,055 | May 13, 2021, 04:43 PM |
Barnes Alane P | Chief Legal Officer | May 11, 2021 | Sale | $12.04 | 102,780 | 1,237,471 | 110,275 | May 13, 2021, 04:43 PM |
ABERCROMBIE GEORGE B | Director | May 10, 2021 | Sale | $12.70 | 7,000 | 88,900 | 3,000 | May 12, 2021, 05:02 PM |
Jones Michael L | Exec. Director, Finance - PAO | Mar 18, 2021 | Option Exercise | $3.51 | 4,500 | 15,795 | 5,348 | Mar 22, 2021, 04:19 PM |
INGRAM ROBERT ALEXANDER | Director | Feb 26, 2021 | Option Exercise | $10.78 | 1,739 | 18,746 | 75,013 | Mar 02, 2021, 04:55 PM |
Hutson Nancy J | Director | Feb 26, 2021 | Option Exercise | $10.78 | 463 | 4,991 | 64,756 | Mar 02, 2021, 04:53 PM |
HEGGIE THERESA | Director | Feb 26, 2021 | Option Exercise | $10.78 | 463 | 4,991 | 13,849 | Mar 02, 2021, 04:50 PM |
ASELAGE STEVE | Director | Feb 26, 2021 | Option Exercise | $10.78 | 927 | 9,993 | 31,496 | Mar 02, 2021, 04:47 PM |
Sheridan William P | Senior VP - CMO | Feb 22, 2021 | Option Exercise | $4.15 | 41,250 | 171,188 | 52,725 | Feb 24, 2021, 04:34 PM |
Sheridan William P | Senior VP - CMO | Feb 22, 2021 | Sale | $11.57 | 41,250 | 477,262 | 11,475 | Feb 24, 2021, 04:34 PM |
Babu Yarlagadda S | Senior VP - Drug Discovery | Feb 19, 2021 | Option Exercise | $11.53 | 22,431 | 258,629 | 183,156 | Feb 23, 2021, 04:25 PM |
Babu Yarlagadda S | Senior VP - Drug Discovery | Feb 19, 2021 | Option Exercise | $4.15 | 50,000 | 207,500 | 205,587 | Feb 23, 2021, 04:25 PM |
Stonehouse Jon P | President & CEO | Dec 15, 2020 | Option Exercise | $4.15 | 134,278 | 557,254 | 918,364 | Dec 17, 2020, 04:20 PM |
Stonehouse Jon P | President & CEO | Dec 15, 2020 | Sale | $8.32 | 134,278 | 1,117,193 | 784,086 | Dec 17, 2020, 04:20 PM |
Barnes Alane P | Senior VP, Chief Legal Officer | Dec 11, 2020 | Option Exercise | $4.15 | 13,741 | 57,025 | 121,802 | Dec 15, 2020, 05:35 PM |
Barnes Alane P | Senior VP, Chief Legal Officer | Dec 11, 2020 | Sale | $7.96 | 13,741 | 109,378 | 108,061 | Dec 15, 2020, 05:35 PM |
Barnes Alane P | Senior VP, Chief Legal Officer | Dec 04, 2020 | Option Exercise | $4.15 | 13,741 | 57,025 | 121,802 | Dec 08, 2020, 04:12 PM |
Barnes Alane P | Senior VP, Chief Legal Officer | Dec 04, 2020 | Sale | $6.23 | 13,741 | 85,606 | 108,061 | Dec 08, 2020, 04:12 PM |
HEGGIE THERESA | Director | Nov 30, 2020 | Option Exercise | $5.11 | 978 | 4,998 | 13,386 | Dec 02, 2020, 04:21 PM |
ASELAGE STEVE | Director | Nov 30, 2020 | Option Exercise | $5.11 | 1,956 | 9,995 | 30,569 | Dec 02, 2020, 04:19 PM |
Hutson Nancy J | Director | Nov 30, 2020 | Option Exercise | $5.11 | 978 | 4,998 | 64,293 | Dec 02, 2020, 04:16 PM |
INGRAM ROBERT ALEXANDER | Director | Nov 30, 2020 | Option Exercise | $5.11 | 3,669 | 18,749 | 73,274 | Dec 02, 2020, 04:14 PM |
Hutson Nancy J | Director | Aug 31, 2020 | Option Exercise | $4.15 | 1,204 | 4,997 | 63,315 | Sep 02, 2020, 04:44 PM |
HEGGIE THERESA | Director | Aug 31, 2020 | Option Exercise | $4.15 | 1,204 | 4,997 | 12,408 | Sep 02, 2020, 04:39 PM |
ASELAGE STEVE | Director | Aug 31, 2020 | Option Exercise | $4.15 | 2,409 | 9,997 | 28,613 | Sep 02, 2020, 04:36 PM |
INGRAM ROBERT ALEXANDER | Director | Aug 31, 2020 | Option Exercise | $4.15 | 4,518 | 18,750 | 69,605 | Sep 02, 2020, 04:33 PM |
Doyle Anthony | Chief Financial Officer | Aug 11, 2020 | Buy | $4.08 | 54,000 | 220,320 | 54,000 | Aug 12, 2020, 04:31 PM |
ASELAGE STEVE | Director | Jun 01, 2020 | Option Exercise | $4.49 | 1,112 | 4,998 | 26,204 | Jun 03, 2020, 04:24 PM |
HEGGIE THERESA | Director | Jun 01, 2020 | Option Exercise | $4.49 | 1,112 | 4,998 | 11,204 | Jun 03, 2020, 04:22 PM |
Hutson Nancy J | Director | Jun 01, 2020 | Option Exercise | $4.49 | 2,224 | 9,997 | 62,111 | Jun 03, 2020, 04:20 PM |
INGRAM ROBERT ALEXANDER | Director | Jun 01, 2020 | Option Exercise | $4.49 | 4,171 | 18,749 | 65,087 | Jun 03, 2020, 04:16 PM |
Hutson Nancy J | Director | Mar 01, 2020 | Option Exercise | $3.00 | 3,333 | 9,999 | 59,887 | Mar 03, 2020, 04:50 PM |
INGRAM ROBERT ALEXANDER | Director | Mar 01, 2020 | Option Exercise | $3.00 | 6,250 | 18,750 | 60,916 | Mar 03, 2020, 04:47 PM |
HEGGIE THERESA | Director | Mar 01, 2020 | Option Exercise | $3.00 | 1,666 | 4,998 | 10,092 | Mar 03, 2020, 12:00 AM |
ASELAGE STEVE | Director | Mar 01, 2020 | Option Exercise | $3.00 | 1,666 | 4,998 | 25,092 | Mar 03, 2020, 12:00 AM |
HEGGIE THERESA | Director | Dec 01, 2019 | Option Exercise | $2.85 | 1,754 | 4,999 | 8,426 | Dec 03, 2019, 05:17 PM |
ASELAGE STEVE | Director | Dec 01, 2019 | Option Exercise | $2.85 | 1,754 | 4,999 | 23,426 | Dec 03, 2019, 05:14 PM |
Hutson Nancy J | Director | Dec 01, 2019 | Option Exercise | $2.85 | 3,508 | 9,998 | 56,554 | Dec 03, 2019, 05:12 PM |
INGRAM ROBERT ALEXANDER | Director | Dec 01, 2019 | Option Exercise | $2.85 | 6,578 | 18,747 | 54,666 | Dec 03, 2019, 05:09 PM |
Stonehouse Jon P | President & CEO | Nov 18, 2019 | Buy | $1.45 | 50,000 | 72,500 | 778,086 | Nov 18, 2019, 04:17 PM |
Sniecinski Megan | Chief Business Officer | Nov 18, 2019 | Buy | $1.45 | 45,000 | 65,250 | 45,000 | Nov 18, 2019, 04:16 PM |
LEE KENNETH B JR | Director | Nov 18, 2019 | Buy | $1.45 | 5,000 | 7,250 | 15,252 | Nov 18, 2019, 04:14 PM |
INGRAM ROBERT ALEXANDER | Director | Nov 18, 2019 | Buy | $1.45 | 20,000 | 29,000 | 48,088 | Nov 18, 2019, 04:12 PM |
Hutson Nancy J | Director | Nov 18, 2019 | Buy | $1.45 | 10,000 | 14,500 | 53,046 | Nov 18, 2019, 04:10 PM |
HEGGIE THERESA | Director | Nov 18, 2019 | Buy | $1.45 | 5,000 | 7,250 | 6,672 | Nov 18, 2019, 04:08 PM |
Barnes Alane P | Senior VP, Chief Legal Officer | Nov 18, 2019 | Buy | $1.45 | 20,000 | 29,000 | 102,061 | Nov 18, 2019, 04:05 PM |
Babu Yarlagadda S | Senior VP - Drug Discovery | Nov 18, 2019 | Buy | $1.45 | 25,000 | 36,250 | 155,587 | Nov 18, 2019, 04:03 PM |
ASELAGE STEVE | Director | Nov 18, 2019 | Buy | $1.45 | 15,000 | 21,750 | 21,672 | Nov 18, 2019, 04:01 PM |
HEGGIE THERESA | Director | Sep 01, 2019 | Option Exercise | $2.99 | 1,672 | 4,999 | 1,672 | Sep 04, 2019, 04:16 PM |
ASELAGE STEVE | Director | Sep 01, 2019 | Option Exercise | $2.99 | 1,672 | 4,999 | 6,672 | Sep 04, 2019, 04:14 PM |
Hutson Nancy J | Director | Sep 01, 2019 | Option Exercise | $2.99 | 3,344 | 9,999 | 43,046 | Sep 04, 2019, 04:12 PM |
INGRAM ROBERT ALEXANDER | Director | Sep 01, 2019 | Option Exercise | $2.99 | 6,270 | 18,747 | 28,088 | Sep 04, 2019, 04:08 PM |
ASELAGE STEVE | Director | May 22, 2019 | Buy | $3.57 | 3,000 | 10,710 | 5,000 | May 24, 2019, 04:20 PM |
STAAB THOMAS R II | Senior Vice President and CFO | May 16, 2019 | Option Exercise | $1.42 | 4,750 | 6,745 | 134,926 | May 20, 2019, 04:21 PM |
STAAB THOMAS R II | Senior Vice President and CFO | May 17, 2019 | Sale | $7.45 | 2,500 | 18,625 | 125,176 | May 20, 2019, 04:21 PM |
STAAB THOMAS R II | Senior Vice President and CFO | May 16, 2019 | Sale | $7.72 | 7,250 | 55,970 | 127,676 | May 20, 2019, 04:21 PM |
STAAB THOMAS R II | Senior Vice President and CFO | May 15, 2019 | Option Exercise | $1.42 | 4,750 | 6,745 | 137,426 | May 16, 2019, 04:29 PM |
STAAB THOMAS R II | Senior Vice President and CFO | May 14, 2019 | Option Exercise | $1.42 | 4,500 | 6,390 | 137,176 | May 16, 2019, 04:29 PM |
STAAB THOMAS R II | Senior Vice President and CFO | May 15, 2019 | Sale | $7.92 | 7,250 | 57,420 | 130,176 | May 16, 2019, 04:29 PM |
STAAB THOMAS R II | Senior Vice President and CFO | May 14, 2019 | Sale | $7.62 | 4,500 | 34,290 | 132,676 | May 16, 2019, 04:29 PM |
STAAB THOMAS R II | Senior Vice President and CFO | May 09, 2019 | Option Exercise | $5.51 | 9,750 | 53,723 | 142,426 | May 13, 2019, 04:57 PM |
STAAB THOMAS R II | Senior Vice President and CFO | May 13, 2019 | Option Exercise | $5.51 | 9,750 | 53,723 | 142,426 | May 13, 2019, 04:57 PM |
STAAB THOMAS R II | Senior Vice President and CFO | May 09, 2019 | Sale | $7.63 | 9,750 | 74,393 | 132,676 | May 13, 2019, 04:57 PM |
STAAB THOMAS R II | Senior Vice President and CFO | May 13, 2019 | Sale | $7.76 | 9,750 | 75,660 | 132,676 | May 13, 2019, 04:57 PM |
STAAB THOMAS R II | Senior Vice President and CFO | May 06, 2019 | Option Exercise | $5.51 | 9,000 | 49,590 | 141,676 | May 06, 2019, 04:51 PM |
STAAB THOMAS R II | Senior Vice President and CFO | May 02, 2019 | Option Exercise | $5.51 | 7,750 | 42,703 | 140,426 | May 06, 2019, 04:51 PM |
STAAB THOMAS R II | Senior Vice President and CFO | May 06, 2019 | Sale | $7.75 | 9,000 | 69,750 | 132,676 | May 06, 2019, 04:51 PM |
STAAB THOMAS R II | Senior Vice President and CFO | May 02, 2019 | Sale | $7.30 | 7,750 | 56,575 | 132,676 | May 06, 2019, 04:51 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Apr 04, 2019 | Option Exercise | $5.51 | 7,500 | 41,325 | 140,176 | Apr 08, 2019, 02:30 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Apr 04, 2019 | Sale | $8.81 | 7,500 | 66,075 | 132,676 | Apr 08, 2019, 02:30 PM |
ASELAGE STEVE | Director | Mar 12, 2019 | Buy | $8.30 | 2,000 | 16,600 | 2,000 | Mar 14, 2019, 04:18 PM |
Babu Yarlagadda S | Senior VP - Drug Discovery | Jan 31, 2019 | Option Exercise | $8.68 | 9,387 | 81,479 | 130,587 | Feb 04, 2019, 04:13 PM |
Babu Yarlagadda S | Senior VP - Drug Discovery | Jan 31, 2019 | Option Exercise | $1.20 | 31,874 | 38,249 | 132,272 | Feb 04, 2019, 04:13 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Jan 28, 2019 | Option Exercise | $5.45 | 5,000 | 27,250 | 133,426 | Jan 30, 2019, 04:10 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Jan 28, 2019 | Sale | $9.85 | 5,000 | 49,250 | 128,426 | Jan 30, 2019, 04:10 PM |
Powell Lynne | Senior VP - CCO | Jan 28, 2019 | Option Exercise | $3.22 | 6,000 | 19,320 | 4,000 | Jan 29, 2019, 04:21 PM |
Powell Lynne | Senior VP - CCO | Jan 25, 2019 | Option Exercise | $3.22 | 6,000 | 19,320 | 6,000 | Jan 29, 2019, 04:21 PM |
Powell Lynne | Senior VP - CCO | Jan 28, 2019 | Sale | $9.89 | 6,000 | 59,340 | 0 | Jan 29, 2019, 04:21 PM |
Powell Lynne | Senior VP - CCO | Jan 25, 2019 | Sale | $9.60 | 6,000 | 57,600 | 0 | Jan 29, 2019, 04:21 PM |
Powell Lynne | Senior VP - CCO | Jan 18, 2019 | Option Exercise | $3.22 | 2,000 | 6,440 | 2,000 | Jan 23, 2019, 04:12 PM |
Powell Lynne | Senior VP - CCO | Jan 18, 2019 | Sale | $9.40 | 2,000 | 18,800 | 0 | Jan 23, 2019, 04:12 PM |
Powell Lynne | Senior VP - CCO | Jan 16, 2019 | Option Exercise | $3.22 | 3,046 | 9,808 | 3,046 | Jan 18, 2019, 04:03 PM |
Powell Lynne | Senior VP - CCO | Jan 16, 2019 | Sale | $9.27 | 3,046 | 28,236 | 0 | Jan 18, 2019, 04:03 PM |
Powell Lynne | Senior VP - CCO | Jan 14, 2019 | Option Exercise | $3.22 | 954 | 3,072 | 954 | Jan 16, 2019, 04:24 PM |
Powell Lynne | Senior VP - CCO | Jan 14, 2019 | Sale | $9.20 | 954 | 8,777 | 0 | Jan 16, 2019, 04:24 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Jan 01, 2019 | Option Exercise | $8.07 | 785 | 6,335 | 132,676 | Jan 03, 2019, 04:30 PM |
Stonehouse Jon P | President & CEO | Jan 01, 2019 | Option Exercise | $8.07 | 3,568 | 28,794 | 724,106 | Jan 03, 2019, 12:00 AM |
Babu Yarlagadda S | Senior VP - Drug Discovery | Jan 01, 2019 | Option Exercise | $8.07 | 771 | 6,222 | 108,100 | Jan 03, 2019, 12:00 AM |
Barnes Alane P | Senior VP, Chief Legal Officer | Jan 01, 2019 | Option Exercise | $8.07 | 423 | 3,414 | 77,530 | Jan 03, 2019, 12:00 AM |
Sheridan William P | Senior VP - CMO | Jan 01, 2019 | Option Exercise | $8.07 | 1,087 | 8,772 | 1,638 | Jan 03, 2019, 12:00 AM |
Sheridan William P | Senior VP - CMO | Dec 18, 2018 | Sale | $7.58 | 20,488 | 155,299 | 2,725 | Dec 20, 2018, 04:37 PM |
Powell Lynne | Senior VP - CCO | Dec 10, 2018 | Option Exercise | $3.22 | 4,000 | 12,880 | 2,000 | Dec 12, 2018, 04:13 PM |
Powell Lynne | Senior VP - CCO | Dec 10, 2018 | Sale | $9.06 | 4,000 | 36,240 | 0 | Dec 12, 2018, 04:13 PM |
Stonehouse Jon P | President & CEO | Dec 03, 2018 | Option Exercise | $1.20 | 80,000 | 96,000 | 807,674 | Dec 06, 2018, 04:34 PM |
Stonehouse Jon P | President & CEO | Dec 03, 2018 | Sale | $9.12 | 80,000 | 729,600 | 727,674 | Dec 06, 2018, 04:34 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Dec 04, 2018 | Sale | $9.45 | 3,922 | 37,063 | 133,461 | Dec 06, 2018, 04:30 PM |
Barnes Alane P | Senior VP, Chief Legal Officer | Nov 30, 2018 | Option Exercise | $1.42 | 25,000 | 35,500 | 122,243 | Dec 04, 2018, 04:11 PM |
Barnes Alane P | Senior VP, Chief Legal Officer | Nov 30, 2018 | Sale | $9.07 | 44,290 | 401,710 | 77,953 | Dec 04, 2018, 04:11 PM |
Erck Stanley C | Director | Nov 28, 2018 | Option Exercise | $1.49 | 8,333 | 12,416 | 48,333 | Nov 30, 2018, 04:02 PM |
Powell Lynne | Senior VP - CCO | Nov 21, 2018 | Option Exercise | $3.22 | 12,000 | 38,640 | 14,455 | Nov 26, 2018, 04:22 PM |
Powell Lynne | Senior VP - CCO | Nov 21, 2018 | Sale | $9.05 | 14,455 | 130,840 | 2,455 | Nov 26, 2018, 04:22 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Nov 23, 2018 | Option Exercise | $3.78 | 3,500 | 13,230 | 140,883 | Nov 26, 2018, 04:19 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Nov 21, 2018 | Option Exercise | $4.48 | 12,000 | 53,710 | 144,383 | Nov 26, 2018, 04:19 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Nov 23, 2018 | Sale | $9.66 | 3,500 | 33,810 | 137,383 | Nov 26, 2018, 04:19 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Nov 21, 2018 | Sale | $9.22 | 12,000 | 110,610 | 137,383 | Nov 26, 2018, 04:19 PM |
Powell Lynne | Senior VP - CCO | Nov 19, 2018 | Option Exercise | $3.22 | 193 | 621 | 8,798 | Nov 21, 2018, 04:51 PM |
Powell Lynne | Senior VP - CCO | Nov 20, 2018 | Option Exercise | $3.22 | 9,127 | 29,389 | 17,732 | Nov 21, 2018, 04:51 PM |
Powell Lynne | Senior VP - CCO | Nov 19, 2018 | Sale | $8.30 | 193 | 1,602 | 8,605 | Nov 21, 2018, 04:51 PM |
Powell Lynne | Senior VP - CCO | Nov 20, 2018 | Sale | $8.56 | 15,277 | 130,714 | 8,605 | Nov 21, 2018, 04:51 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Nov 20, 2018 | Option Exercise | $3.45 | 11,123 | 38,405 | 143,883 | Nov 21, 2018, 04:48 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Nov 19, 2018 | Option Exercise | $3.78 | 75 | 283 | 137,458 | Nov 21, 2018, 04:48 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Nov 20, 2018 | Sale | $8.68 | 11,123 | 96,494 | 137,383 | Nov 21, 2018, 04:48 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Nov 19, 2018 | Sale | $8.30 | 75 | 623 | 137,383 | Nov 21, 2018, 04:48 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Nov 08, 2018 | Option Exercise | $3.32 | 13,415 | 44,485 | 148,496 | Nov 09, 2018, 04:14 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Nov 07, 2018 | Option Exercise | $3.22 | 672 | 2,164 | 138,055 | Nov 09, 2018, 04:14 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Nov 07, 2018 | Sale | $8.00 | 672 | 5,376 | 137,383 | Nov 09, 2018, 04:14 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Nov 08, 2018 | Sale | $8.13 | 13,415 | 109,011 | 137,383 | Nov 09, 2018, 04:14 PM |
Powell Lynne | Senior VP - CCO | Nov 07, 2018 | Option Exercise | $3.22 | 300 | 966 | 8,905 | Nov 09, 2018, 04:11 PM |
Powell Lynne | Senior VP - CCO | Nov 08, 2018 | Option Exercise | $3.22 | 5,280 | 17,002 | 13,885 | Nov 09, 2018, 04:11 PM |
Powell Lynne | Senior VP - CCO | Nov 08, 2018 | Sale | $8.15 | 5,280 | 43,032 | 8,605 | Nov 09, 2018, 04:11 PM |
Powell Lynne | Senior VP - CCO | Nov 07, 2018 | Sale | $8.00 | 300 | 2,400 | 8,605 | Nov 09, 2018, 04:11 PM |
Powell Lynne | Senior VP - CCO | Nov 05, 2018 | Option Exercise | $3.22 | 100 | 322 | 8,705 | Nov 07, 2018, 04:05 PM |
Powell Lynne | Senior VP - CCO | Nov 05, 2018 | Sale | $8.00 | 100 | 800 | 8,605 | Nov 07, 2018, 04:05 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Nov 05, 2018 | Option Exercise | $3.22 | 215 | 692 | 137,598 | Nov 07, 2018, 04:03 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Nov 05, 2018 | Sale | $8.00 | 215 | 1,720 | 137,383 | Nov 07, 2018, 04:03 PM |
Powell Lynne | Senior VP - CCO | Nov 02, 2018 | Option Exercise | $3.22 | 1,000 | 3,220 | 9,605 | Nov 06, 2018, 04:07 PM |
Powell Lynne | Senior VP - CCO | Nov 02, 2018 | Sale | $8.00 | 1,000 | 8,000 | 8,605 | Nov 06, 2018, 04:07 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Nov 02, 2018 | Option Exercise | $3.40 | 10,856 | 36,916 | 144,739 | Nov 06, 2018, 04:04 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Nov 02, 2018 | Sale | $7.84 | 10,856 | 85,090 | 137,383 | Nov 06, 2018, 04:04 PM |
Powell Lynne | Senior VP - CCO | Nov 01, 2018 | Sale | $7.51 | 1,544 | 11,595 | 8,605 | Nov 05, 2018, 01:17 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Oct 19, 2018 | Option Exercise | $3.78 | 3,150 | 11,907 | 140,533 | Oct 23, 2018, 01:34 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Oct 19, 2018 | Sale | $7.45 | 3,150 | 23,467 | 137,383 | Oct 23, 2018, 01:34 PM |
Powell Lynne | Senior VP - CCO | Oct 19, 2018 | Sale | $7.50 | 100 | 750 | 10,149 | Oct 23, 2018, 01:31 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Oct 03, 2018 | Option Exercise | $3.27 | 1,072 | 3,508 | 138,355 | Oct 04, 2018, 01:09 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Oct 02, 2018 | Option Exercise | $3.43 | 8,778 | 30,085 | 142,911 | Oct 04, 2018, 01:09 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Oct 02, 2018 | Sale | $7.24 | 8,778 | 63,556 | 137,383 | Oct 04, 2018, 01:09 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Oct 03, 2018 | Sale | $7.28 | 1,072 | 7,802 | 137,383 | Oct 04, 2018, 01:09 PM |
Sheridan William P | Senior VP - CMO | Aug 09, 2018 | Option Exercise | $1.42 | 62,500 | 88,750 | 85,713 | Aug 13, 2018, 10:07 AM |
Sheridan William P | Senior VP - CMO | Aug 09, 2018 | Sale | $7.03 | 62,500 | 439,375 | 23,213 | Aug 13, 2018, 10:07 AM |
Sheridan William P | Senior VP - CMO | Jun 01, 2018 | Option Exercise | $2.58 | 42,112 | 108,649 | 63,170 | Jun 05, 2018, 03:07 PM |
Sheridan William P | Senior VP - CMO | Jun 01, 2018 | Sale | $6.30 | 42,112 | 265,306 | 21,058 | Jun 05, 2018, 03:07 PM |
INGRAM ROBERT ALEXANDER | Director | Jun 01, 2018 | Option Exercise | $6.43 | 2,916 | 18,750 | 21,818 | Jun 04, 2018, 02:54 PM |
Hutson Nancy J | Director | Jun 01, 2018 | Option Exercise | $6.43 | 1,555 | 9,999 | 39,702 | Jun 04, 2018, 02:48 PM |
Stonehouse Jon P | President & CEO | May 17, 2018 | Option Exercise | $1.42 | 70,427 | 100,006 | 725,519 | May 21, 2018, 09:31 AM |
Barnes Alane P | VP, General Counsel & Corp Sec | May 15, 2018 | Option Exercise | $5.91 | 3,004 | 17,754 | 95,264 | May 17, 2018, 09:25 AM |
Barnes Alane P | VP, General Counsel & Corp Sec | May 15, 2018 | Option Exercise | $1.42 | 12,500 | 17,750 | 98,268 | May 17, 2018, 09:25 AM |
Babu Yarlagadda S | Senior VP - Drug Discovery | Mar 06, 2018 | Option Exercise | $5.18 | 21,125 | 109,427 | 108,871 | Mar 08, 2018, 03:48 PM |
Babu Yarlagadda S | Senior VP - Drug Discovery | Mar 06, 2018 | Option Exercise | $3.26 | 30,000 | 97,800 | 120,618 | Mar 08, 2018, 03:48 PM |
Stonehouse Jon P | President & CEO | Feb 28, 2018 | Option Exercise | $4.97 | 43,224 | 214,823 | 655,092 | Mar 02, 2018, 02:23 PM |
Stonehouse Jon P | President & CEO | Feb 28, 2018 | Option Exercise | $3.26 | 56,949 | 185,654 | 698,316 | Mar 02, 2018, 02:23 PM |
Barnes Alane P | VP, General Counsel & Corp Sec | Feb 28, 2018 | Option Exercise | $3.26 | 6,709 | 21,871 | 85,768 | Mar 02, 2018, 02:21 PM |
INGRAM ROBERT ALEXANDER | Director | Mar 01, 2018 | Option Exercise | $4.97 | 3,772 | 18,747 | 18,902 | Mar 02, 2018, 02:14 PM |
Hutson Nancy J | Director | Mar 01, 2018 | Option Exercise | $4.97 | 2,012 | 10,000 | 38,147 | Mar 02, 2018, 02:11 PM |
Barnes Alane P | VP, General Counsel & Corp Sec | Jan 20, 2018 | Option Exercise | $5.59 | 1,961 | 10,962 | 77,129 | Jan 23, 2018, 09:12 AM |
Babu Yarlagadda S | Senior VP - Drug Discovery | Jan 20, 2018 | Option Exercise | $5.59 | 3,872 | 21,644 | 99,996 | Jan 23, 2018, 09:10 AM |
Sheridan William P | Senior VP - CMO | Jan 20, 2018 | Option Exercise | $5.59 | 4,628 | 25,871 | 18,058 | Jan 23, 2018, 09:08 AM |
STAAB THOMAS R II | Senior Vice President and CFO | Jan 20, 2018 | Option Exercise | $5.59 | 3,979 | 22,243 | 137,383 | Jan 23, 2018, 09:06 AM |
Stonehouse Jon P | President & CEO | Jan 20, 2018 | Option Exercise | $5.59 | 9,584 | 53,575 | 638,367 | Jan 23, 2018, 09:03 AM |
Barnes Alane P | VP, General Counsel & Corp Sec | Jan 01, 2018 | Option Exercise | $4.91 | 459 | 2,254 | 79,090 | Jan 03, 2018, 09:13 AM |
Babu Yarlagadda S | Senior VP - Drug Discovery | Jan 01, 2018 | Option Exercise | $4.91 | 838 | 4,115 | 103,868 | Jan 03, 2018, 09:11 AM |
Sheridan William P | Senior VP - CMO | Jan 01, 2018 | Option Exercise | $4.91 | 1,169 | 5,740 | 22,686 | Jan 03, 2018, 09:04 AM |
STAAB THOMAS R II | Senior Vice President and CFO | Jan 01, 2018 | Option Exercise | $4.91 | 852 | 4,183 | 141,362 | Jan 03, 2018, 09:02 AM |
Stonehouse Jon P | President & CEO | Jan 01, 2018 | Option Exercise | $4.91 | 2,716 | 13,336 | 647,951 | Jan 03, 2018, 08:59 AM |
INGRAM ROBERT ALEXANDER | Director | Dec 01, 2017 | Option Exercise | $5.08 | 3,690 | 18,745 | 15,130 | Dec 04, 2017, 03:53 PM |
Hutson Nancy J | Director | Dec 01, 2017 | Option Exercise | $5.08 | 1,968 | 9,997 | 36,135 | Dec 04, 2017, 03:50 PM |
Sheridan William P | Senior VP - CMO | Nov 13, 2017 | Sale | $4.72 | 64,310 | 303,543 | 23,855 | Nov 15, 2017, 04:09 PM |
Cohen Fred E | Director | Sep 18, 2017 | Option Exercise | $4.27 | 54,250 | 231,647 | 173,660 | Sep 20, 2017, 10:07 AM |
Cohen Fred E | Director | Sep 18, 2017 | Sale | $5.42 | 54,250 | 294,035 | 119,410 | Sep 20, 2017, 10:07 AM |
INGRAM ROBERT ALEXANDER | Director | Sep 01, 2017 | Option Exercise | $5.10 | 3,676 | 18,748 | 11,440 | Sep 05, 2017, 11:29 AM |
Hutson Nancy J | Director | Sep 01, 2017 | Option Exercise | $5.10 | 1,960 | 9,996 | 34,167 | Sep 05, 2017, 11:27 AM |
INGRAM ROBERT ALEXANDER | Director | Jun 01, 2017 | Option Exercise | $5.15 | 1,941 | 9,996 | 7,764 | Jun 02, 2017, 04:04 PM |
Hutson Nancy J | Director | Jun 01, 2017 | Option Exercise | $5.15 | 1,941 | 9,996 | 32,207 | Jun 02, 2017, 04:01 PM |
Cohen Fred E | Director | Jun 01, 2017 | Option Exercise | $5.15 | 1,941 | 9,996 | 119,410 | Jun 02, 2017, 03:59 PM |
STAAB THOMAS R II | Senior Vice President and CFO | May 22, 2017 | Option Exercise | $5.24 | 6,996 | 36,659 | 142,214 | May 24, 2017, 04:33 PM |
STAAB THOMAS R II | Senior Vice President and CFO | May 22, 2017 | Option Exercise | $4.73 | 7,750 | 36,658 | 149,210 | May 24, 2017, 04:33 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Mar 20, 2017 | Option Exercise | $3.78 | 3,250 | 12,285 | 144,710 | Mar 22, 2017, 10:40 AM |
STAAB THOMAS R II | Senior Vice President and CFO | Mar 20, 2017 | Sale | $9.20 | 3,250 | 29,900 | 141,460 | Mar 22, 2017, 10:40 AM |
STAAB THOMAS R II | Senior Vice President and CFO | Mar 16, 2017 | Option Exercise | $8.80 | 12,308 | 108,310 | 141,460 | Mar 20, 2017, 03:01 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Mar 16, 2017 | Option Exercise | $2.97 | 36,455 | 108,300 | 153,768 | Mar 20, 2017, 03:01 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Mar 10, 2017 | Option Exercise | $3.78 | 3,250 | 12,285 | 120,563 | Mar 14, 2017, 01:47 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Mar 10, 2017 | Sale | $9.06 | 3,250 | 29,445 | 117,313 | Mar 14, 2017, 01:47 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Mar 08, 2017 | Option Exercise | $3.78 | 6,500 | 24,570 | 123,813 | Mar 10, 2017, 04:19 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Mar 08, 2017 | Sale | $8.42 | 6,500 | 54,762 | 120,563 | Mar 10, 2017, 04:19 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Mar 06, 2017 | Option Exercise | $3.78 | 3,250 | 12,285 | 120,563 | Mar 08, 2017, 08:05 AM |
STAAB THOMAS R II | Senior Vice President and CFO | Mar 06, 2017 | Sale | $7.90 | 3,250 | 25,675 | 117,313 | Mar 08, 2017, 08:05 AM |
INGRAM ROBERT ALEXANDER | Director | Mar 02, 2017 | Option Exercise | $6.24 | 1,602 | 9,996 | 5,823 | Mar 02, 2017, 03:07 PM |
Hutson Nancy J | Director | Mar 01, 2017 | Option Exercise | $6.24 | 1,602 | 9,996 | 30,266 | Mar 02, 2017, 03:05 PM |
Cohen Fred E | Director | Mar 01, 2017 | Option Exercise | $6.24 | 1,602 | 9,996 | 117,469 | Mar 02, 2017, 03:03 PM |
Barnes Alane P | VP, General Counsel & Corp Sec | Jan 20, 2017 | Option Exercise | $5.95 | 2,599 | 15,464 | 75,497 | Jan 24, 2017, 09:28 AM |
Babu Yarlagadda S | Senior VP - Drug Discovery | Jan 20, 2017 | Option Exercise | $5.95 | 5,083 | 30,244 | 104,706 | Jan 24, 2017, 09:25 AM |
Sheridan William P | Senior VP - CMO | Jan 20, 2017 | Option Exercise | $5.95 | 5,761 | 34,278 | 82,916 | Jan 24, 2017, 09:22 AM |
STAAB THOMAS R II | Senior Vice President and CFO | Jan 20, 2017 | Option Exercise | $5.95 | 5,198 | 30,928 | 117,313 | Jan 24, 2017, 09:20 AM |
Stonehouse Jon P | President & CEO | Jan 20, 2017 | Option Exercise | $5.95 | 10,572 | 62,903 | 645,418 | Jan 24, 2017, 09:17 AM |
Barnes Alane P | VP, General Counsel & Corp Sec | Jan 01, 2017 | Option Exercise | $6.33 | 1,281 | 8,109 | 78,096 | Jan 03, 2017, 02:13 PM |
Babu Yarlagadda S | Senior VP - Drug Discovery | Jan 01, 2017 | Option Exercise | $6.33 | 1,639 | 10,375 | 109,789 | Jan 03, 2017, 02:09 PM |
Sheridan William P | Senior VP - CMO | Jan 01, 2017 | Option Exercise | $6.33 | 2,081 | 13,173 | 88,677 | Jan 03, 2017, 02:06 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Jan 01, 2017 | Option Exercise | $6.33 | 1,676 | 10,609 | 122,511 | Jan 03, 2017, 02:03 PM |
Stonehouse Jon P | President & CEO | Jan 01, 2017 | Option Exercise | $6.33 | 8,595 | 54,406 | 655,990 | Jan 03, 2017, 01:59 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Dec 19, 2016 | Option Exercise | $3.78 | 3,250 | 12,285 | 127,437 | Dec 21, 2016, 10:42 AM |
STAAB THOMAS R II | Senior Vice President and CFO | Dec 19, 2016 | Sale | $7.45 | 3,250 | 24,212 | 124,187 | Dec 21, 2016, 10:42 AM |
INGRAM ROBERT ALEXANDER | Director | Dec 01, 2016 | Option Exercise | $5.59 | 1,788 | 9,995 | 4,221 | Dec 02, 2016, 02:09 PM |
Hutson Nancy J | Director | Dec 01, 2016 | Option Exercise | $5.59 | 1,788 | 9,995 | 28,664 | Dec 02, 2016, 02:06 PM |
Cohen Fred E | Director | Dec 01, 2016 | Option Exercise | $5.59 | 1,788 | 9,995 | 115,867 | Dec 02, 2016, 02:03 PM |
Barnes Alane P | VP, General Counsel & Corp Sec | Sep 14, 2016 | Sale | $4.27 | 8,357 | 35,684 | 79,377 | Sep 16, 2016, 10:54 AM |
INGRAM ROBERT ALEXANDER | Director | Sep 01, 2016 | Option Exercise | $4.11 | 2,433 | 10,000 | 2,433 | Sep 06, 2016, 03:27 PM |
Hutson Nancy J | Director | Sep 01, 2016 | Option Exercise | $4.11 | 2,433 | 10,000 | 26,876 | Sep 06, 2016, 03:25 PM |
Cohen Fred E | Director | Sep 01, 2016 | Option Exercise | $4.11 | 2,433 | 10,000 | 114,079 | Sep 06, 2016, 03:24 PM |
Babu Yarlagadda S | Senior VP - Drug Discovery | Aug 25, 2016 | Sale | $4.06 | 30,000 | 121,800 | 111,428 | Aug 29, 2016, 10:46 AM |
BAKER BROS. ADVISORS LP | 10% Owner | Aug 16, 2016 | Sale | $4.29 | 990 | 4,246 | 9,418,390 | Aug 16, 2016, 06:11 PM |
BAKER BROS. ADVISORS LP | 10% Owner | Aug 15, 2016 | Sale | $4.83 | 400,000 | 1,931,040 | 9,419,240 | Aug 16, 2016, 06:11 PM |
BAKER BROS. ADVISORS LP | 10% Owner | Aug 12, 2016 | Sale | $5.02 | 3,645,600 | 18,315,817 | 10,059,679 | Aug 16, 2016, 06:11 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Aug 12, 2016 | Sale | $5.22 | 4,558 | 23,793 | 124,187 | Aug 15, 2016, 02:07 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Aug 11, 2016 | Sale | $5.05 | 1,306 | 6,595 | 128,745 | Aug 15, 2016, 02:07 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Aug 09, 2016 | Sale | $4.43 | 14,577 | 64,576 | 130,051 | Aug 11, 2016, 01:53 PM |
Hutson Nancy J | Director | May 31, 2016 | Option Exercise | $3.39 | 2,581 | 8,750 | 24,443 | Jun 02, 2016, 09:45 AM |
Cohen Fred E | Director | May 31, 2016 | Option Exercise | $3.39 | 2,581 | 8,750 | 111,646 | Jun 02, 2016, 09:42 AM |
Barnes Alane P | VP, General Counsel & Corp Sec | Mar 01, 2016 | Option Exercise | $2.13 | 687 | 1,463 | 85,416 | Mar 03, 2016, 09:56 AM |
Babu Yarlagadda S | Senior VP - Drug Discovery | Mar 01, 2016 | Option Exercise | $2.13 | 906 | 1,930 | 141,428 | Mar 03, 2016, 09:47 AM |
Sheridan William P | Senior VP - CMO | Mar 01, 2016 | Option Exercise | $2.13 | 799 | 1,702 | 90,052 | Mar 03, 2016, 09:45 AM |
STAAB THOMAS R II | Senior Vice President and CFO | Mar 01, 2016 | Option Exercise | $2.13 | 465 | 990 | 144,628 | Mar 03, 2016, 09:43 AM |
Stonehouse Jon P | President & CEO | Mar 01, 2016 | Option Exercise | $2.13 | 2,761 | 5,881 | 664,585 | Mar 03, 2016, 09:41 AM |
SANDERS CHARLES A | Director | Feb 29, 2016 | Option Exercise | $1.99 | 4,396 | 8,748 | 12,971 | Mar 01, 2016, 04:08 PM |
Hutson Nancy J | Director | Feb 29, 2016 | Option Exercise | $1.99 | 4,396 | 8,748 | 21,862 | Mar 01, 2016, 04:05 PM |
Cohen Fred E | Director | Feb 29, 2016 | Option Exercise | $1.99 | 4,396 | 8,748 | 109,065 | Mar 01, 2016, 04:03 PM |
BAKER BROS. ADVISORS LP | 10% Owner | Feb 05, 2016 | Buy | $6.33 | 45,000 | 284,656 | 12,894,240 | Feb 09, 2016, 05:24 PM |
BAKER BROS. ADVISORS LP | 10% Owner | Feb 04, 2016 | Buy | $6.65 | 24,800 | 164,915 | 12,849,240 | Feb 04, 2016, 05:15 PM |
BAKER BROS. ADVISORS LP | 10% Owner | Feb 03, 2016 | Buy | $6.29 | 91,187 | 573,311 | 12,824,440 | Feb 04, 2016, 05:15 PM |
BAKER BROS. ADVISORS LP | 10% Owner | Feb 02, 2016 | Buy | $6.52 | 91,728 | 598,360 | 12,733,253 | Feb 04, 2016, 05:15 PM |
Barnes Alane P | VP, General Counsel & Corp Sec | Jan 29, 2016 | Option Exercise | $1.42 | 19,368 | 27,503 | 85,057 | Feb 01, 2016, 02:34 PM |
BAKER BROS. ADVISORS LP | 10% Owner | Jan 27, 2016 | Buy | $6.98 | 63,345 | 441,971 | 12,616,525 | Jan 29, 2016, 04:42 PM |
BAKER BROS. ADVISORS LP | 10% Owner | Jan 28, 2016 | Buy | $6.88 | 25,000 | 172,015 | 12,641,525 | Jan 29, 2016, 04:42 PM |
Powell Lynne | Senior VP - CCO | Jan 26, 2016 | Option Exercise | $7.29 | 3,850 | 28,066 | 8,605 | Jan 27, 2016, 01:41 PM |
BAKER BROS. ADVISORS LP | 10% Owner | Jan 22, 2016 | Buy | $7.00 | 3,200 | 22,389 | 12,553,180 | Jan 25, 2016, 06:10 PM |
BAKER BROS. ADVISORS LP | 10% Owner | Jan 21, 2016 | Buy | $7.29 | 103,600 | 755,368 | 12,549,980 | Jan 25, 2016, 06:10 PM |
Barnes Alane P | VP, General Counsel & Corp Sec | Jan 20, 2016 | Option Exercise | $7.55 | 2,599 | 19,622 | 65,689 | Jan 22, 2016, 09:27 AM |
Babu Yarlagadda S | Senior VP - Drug Discovery | Jan 20, 2016 | Option Exercise | $7.55 | 4,724 | 35,666 | 142,334 | Jan 22, 2016, 09:24 AM |
Sheridan William P | Senior VP - CMO | Jan 20, 2016 | Option Exercise | $7.55 | 5,359 | 40,460 | 88,967 | Jan 22, 2016, 09:21 AM |
STAAB THOMAS R II | Senior Vice President and CFO | Jan 20, 2016 | Option Exercise | $7.55 | 4,823 | 36,414 | 145,093 | Jan 22, 2016, 09:18 AM |
Stonehouse Jon P | President & CEO | Jan 20, 2016 | Option Exercise | $7.55 | 10,624 | 80,211 | 665,702 | Jan 22, 2016, 09:16 AM |
Stonehouse Jon P | President & CEO | Jan 20, 2016 | Option Exercise | $4.15 | 24,096 | 99,998 | 676,326 | Jan 21, 2016, 01:12 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Jan 19, 2016 | Option Exercise | $1.81 | 15,000 | 27,200 | 149,916 | Jan 21, 2016, 11:04 AM |
BAKER BROS. ADVISORS LP | 10% Owner | Jan 15, 2016 | Buy | $7.46 | 200,000 | 1,491,222 | 12,301,485 | Jan 20, 2016, 07:13 PM |
BAKER BROS. ADVISORS LP | 10% Owner | Jan 20, 2016 | Buy | $6.87 | 52,695 | 362,171 | 12,446,380 | Jan 20, 2016, 07:13 PM |
BAKER BROS. ADVISORS LP | 10% Owner | Jan 19, 2016 | Buy | $7.12 | 92,200 | 656,750 | 12,393,685 | Jan 20, 2016, 07:13 PM |
Barnes Alane P | VP, General Counsel & Corp Sec | Jan 01, 2016 | Option Exercise | $10.32 | 1,281 | 13,220 | 68,288 | Jan 05, 2016, 01:31 PM |
Babu Yarlagadda S | Senior VP - Drug Discovery | Jan 01, 2016 | Option Exercise | $10.32 | 1,639 | 16,914 | 147,058 | Jan 05, 2016, 01:29 PM |
Sheridan William P | Senior VP - CMO | Jan 01, 2016 | Option Exercise | $10.32 | 2,081 | 21,476 | 94,326 | Jan 05, 2016, 01:27 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Jan 01, 2016 | Option Exercise | $10.32 | 1,676 | 17,296 | 134,916 | Jan 05, 2016, 01:25 PM |
Stonehouse Jon P | President & CEO | Jan 01, 2016 | Option Exercise | $10.32 | 8,091 | 83,499 | 652,230 | Jan 05, 2016, 01:23 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Dec 21, 2015 | Sale | $10.86 | 3,052 | 33,145 | 136,592 | Dec 22, 2015, 03:45 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Dec 17, 2015 | Sale | $10.49 | 3,000 | 31,470 | 139,644 | Dec 18, 2015, 02:54 PM |
SANDERS CHARLES A | Director | Nov 30, 2015 | Option Exercise | $10.61 | 824 | 8,743 | 8,575 | Dec 03, 2015, 04:22 PM |
Hutson Nancy J | Director | Nov 30, 2015 | Option Exercise | $10.61 | 824 | 8,743 | 17,466 | Dec 03, 2015, 04:20 PM |
Cohen Fred E | Director | Nov 30, 2015 | Option Exercise | $10.61 | 824 | 8,743 | 104,669 | Dec 03, 2015, 04:19 PM |
SANDERS CHARLES A | Director | Aug 31, 2015 | Option Exercise | $11.64 | 751 | 8,742 | 7,751 | Sep 02, 2015, 02:27 PM |
Hutson Nancy J | Director | Aug 31, 2015 | Option Exercise | $11.64 | 751 | 8,742 | 16,642 | Sep 02, 2015, 02:24 PM |
Cohen Fred E | Director | Aug 31, 2015 | Option Exercise | $11.64 | 751 | 8,742 | 103,845 | Sep 02, 2015, 02:22 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Jul 20, 2015 | Sale | $16.50 | 3,500 | 57,750 | 142,644 | Jul 22, 2015, 05:21 PM |
Stonehouse Jon P | President & CEO | Jul 15, 2015 | Option Exercise | $15.67 | 25,526 | 399,992 | 659,211 | Jul 17, 2015, 09:45 AM |
Stonehouse Jon P | President & CEO | Jul 15, 2015 | Option Exercise | $11.81 | 33,868 | 399,981 | 684,737 | Jul 17, 2015, 09:45 AM |
STAAB THOMAS R II | Senior Vice President and CFO | Jun 22, 2015 | Option Exercise | $4.73 | 3,750 | 17,738 | 149,894 | Jun 24, 2015, 04:57 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Jun 22, 2015 | Sale | $16.00 | 3,750 | 60,000 | 146,144 | Jun 24, 2015, 04:57 PM |
Barnes Alane P | VP, General Counsel & Corp Sec | Jun 19, 2015 | Sale | $15.00 | 3,000 | 45,000 | 68,876 | Jun 22, 2015, 04:51 PM |
Sheridan William P | Senior VP - CMO | Jun 19, 2015 | Option Exercise | $1.20 | 70,389 | 84,467 | 165,512 | Jun 22, 2015, 04:48 PM |
Sheridan William P | Senior VP - CMO | Jun 19, 2015 | Sale | $15.05 | 70,389 | 1,059,354 | 95,123 | Jun 22, 2015, 04:48 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Jun 19, 2015 | Option Exercise | $3.78 | 3,175 | 12,001 | 149,319 | Jun 22, 2015, 04:38 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Jun 18, 2015 | Option Exercise | $3.78 | 6,200 | 23,436 | 155,844 | Jun 22, 2015, 04:38 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Jun 19, 2015 | Sale | $15.00 | 6,675 | 100,125 | 146,144 | Jun 22, 2015, 04:38 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Jun 18, 2015 | Sale | $13.92 | 9,700 | 135,025 | 152,744 | Jun 22, 2015, 04:38 PM |
Stonehouse Jon P | President & CEO | Jun 19, 2015 | Option Exercise | $1.20 | 20,000 | 24,000 | 670,869 | Jun 22, 2015, 04:34 PM |
Stonehouse Jon P | President & CEO | Jun 19, 2015 | Sale | $15.02 | 20,000 | 300,400 | 650,869 | Jun 22, 2015, 04:34 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Jun 05, 2015 | Sale | $12.75 | 6,000 | 76,500 | 153,144 | Jun 09, 2015, 01:33 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Jun 01, 2015 | Sale | $12.00 | 3,000 | 36,000 | 159,144 | Jun 02, 2015, 02:57 PM |
Cohen Fred E | Director | May 29, 2015 | Option Exercise | $11.21 | 780 | 8,744 | 103,094 | Jun 01, 2015, 03:53 PM |
STAAB THOMAS R II | Senior Vice President and CFO | May 18, 2015 | Sale | $11.00 | 3,000 | 33,000 | 162,144 | May 19, 2015, 04:53 PM |
Babu Yarlagadda S | Senior VP - Drug Discovery | Mar 19, 2015 | Sale | $10.16 | 12,105 | 122,987 | 148,697 | Mar 20, 2015, 04:30 PM |
Babu Yarlagadda S | Senior VP - Drug Discovery | Mar 05, 2015 | Sale | $10.59 | 37,400 | 396,066 | 160,802 | Mar 06, 2015, 02:14 PM |
Babu Yarlagadda S | Senior VP - Drug Discovery | Mar 04, 2015 | Sale | $10.50 | 10,495 | 110,198 | 198,202 | Mar 05, 2015, 02:58 PM |
Barnes Alane P | VP, General Counsel & Corp Sec | Mar 01, 2015 | Option Exercise | $10.20 | 1,120 | 11,424 | 71,876 | Mar 03, 2015, 03:59 PM |
Babu Yarlagadda S | Senior VP - Drug Discovery | Mar 01, 2015 | Option Exercise | $10.20 | 1,634 | 16,667 | 208,697 | Mar 03, 2015, 03:56 PM |
Sheridan William P | Senior VP - CMO | Mar 01, 2015 | Option Exercise | $10.20 | 1,739 | 17,738 | 95,123 | Mar 03, 2015, 03:54 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Mar 01, 2015 | Option Exercise | $10.20 | 465 | 4,743 | 165,144 | Mar 03, 2015, 03:51 PM |
Stonehouse Jon P | President & CEO | Mar 01, 2015 | Option Exercise | $10.20 | 5,118 | 52,204 | 650,869 | Mar 03, 2015, 03:48 PM |
Cohen Fred E | Director | Feb 27, 2015 | Option Exercise | $10.20 | 857 | 8,741 | 102,314 | Mar 03, 2015, 03:45 PM |
Hutson Nancy J | Director | Feb 20, 2015 | Buy | $10.27 | 10,000 | 102,700 | 15,891 | Feb 23, 2015, 12:50 PM |
Barnes Alane P | VP, General Counsel & Corp Sec | Jan 20, 2015 | Option Exercise | $11.17 | 2,210 | 24,686 | 72,370 | Jan 22, 2015, 12:18 PM |
Babu Yarlagadda S | Senior VP - Drug Discovery | Jan 20, 2015 | Option Exercise | $11.17 | 4,362 | 48,724 | 210,331 | Jan 22, 2015, 12:16 PM |
Sheridan William P | Senior VP - CMO | Jan 20, 2015 | Option Exercise | $11.17 | 5,074 | 56,677 | 95,609 | Jan 22, 2015, 12:14 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Jan 20, 2015 | Option Exercise | $11.17 | 4,476 | 49,997 | 164,913 | Jan 22, 2015, 12:12 PM |
Stonehouse Jon P | President & CEO | Jan 20, 2015 | Option Exercise | $11.17 | 10,608 | 118,491 | 654,280 | Jan 22, 2015, 12:10 PM |
Cohen Fred E | Director | Jan 08, 2015 | Option Exercise | $1.29 | 100,000 | 129,000 | 101,457 | Jan 09, 2015, 01:19 PM |
Barnes Alane P | VP, General Counsel & Corp Sec | Jan 01, 2015 | Option Exercise | $12.16 | 2,453 | 29,828 | 74,580 | Jan 05, 2015, 04:12 PM |
Babu Yarlagadda S | Senior VP - Drug Discovery | Jan 01, 2015 | Option Exercise | $12.16 | 2,402 | 29,208 | 214,693 | Jan 05, 2015, 04:10 PM |
Sheridan William P | Senior VP - CMO | Jan 01, 2015 | Option Exercise | $12.16 | 2,735 | 33,258 | 100,683 | Jan 05, 2015, 04:07 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Jan 01, 2015 | Option Exercise | $12.16 | 2,453 | 29,828 | 169,389 | Jan 05, 2015, 04:05 PM |
Stonehouse Jon P | President & CEO | Jan 01, 2015 | Option Exercise | $12.16 | 5,652 | 68,728 | 664,888 | Jan 05, 2015, 04:03 PM |
Sheridan William P | Senior VP - CMO | Dec 30, 2014 | Option Exercise | $1.42 | 23,104 | 32,808 | 115,622 | Dec 31, 2014, 02:11 PM |
Sheridan William P | Senior VP - CMO | Dec 29, 2014 | Option Exercise | $4.25 | 48,396 | 205,742 | 197,813 | Dec 31, 2014, 02:11 PM |
Sheridan William P | Senior VP - CMO | Dec 30, 2014 | Sale | $12.06 | 23,104 | 278,634 | 92,518 | Dec 31, 2014, 02:11 PM |
Sheridan William P | Senior VP - CMO | Dec 29, 2014 | Sale | $12.43 | 105,295 | 1,308,817 | 92,518 | Dec 31, 2014, 02:11 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Dec 29, 2014 | Option Exercise | $3.78 | 9,500 | 35,910 | 172,442 | Dec 31, 2014, 02:09 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Dec 29, 2014 | Sale | $12.56 | 9,500 | 119,320 | 162,942 | Dec 31, 2014, 02:09 PM |
Cohen Fred E | Director | Nov 28, 2014 | Option Exercise | $10.81 | 809 | 8,745 | 1,457 | Dec 03, 2014, 03:41 PM |
Cohen Fred E | Director | Aug 29, 2014 | Option Exercise | $13.50 | 648 | 8,748 | 648 | Sep 02, 2014, 04:08 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Aug 27, 2014 | Option Exercise | $5.45 | 10,000 | 54,500 | 172,942 | Aug 29, 2014, 11:04 AM |
STAAB THOMAS R II | Senior Vice President and CFO | Aug 27, 2014 | Sale | $13.58 | 10,000 | 135,800 | 162,942 | Aug 29, 2014, 11:04 AM |
STAAB THOMAS R II | Senior Vice President and CFO | Jul 25, 2014 | Option Exercise | $11.76 | 8,504 | 100,007 | 162,252 | Jul 28, 2014, 01:21 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Jul 25, 2014 | Option Exercise | $3.78 | 26,455 | 100,000 | 170,756 | Jul 28, 2014, 01:21 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Jul 01, 2014 | Option Exercise | $4.73 | 3,125 | 14,781 | 147,426 | Jul 02, 2014, 04:33 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Jul 01, 2014 | Sale | $13.00 | 3,125 | 40,625 | 144,301 | Jul 02, 2014, 04:33 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Jun 23, 2014 | Option Exercise | $4.73 | 3,125 | 14,781 | 147,426 | Jun 24, 2014, 03:41 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Jun 23, 2014 | Sale | $12.49 | 3,125 | 39,031 | 144,301 | Jun 24, 2014, 03:41 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Jun 17, 2014 | Option Exercise | $4.73 | 3,125 | 14,781 | 147,426 | Jun 19, 2014, 04:47 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Jun 17, 2014 | Sale | $12.00 | 3,125 | 37,500 | 144,301 | Jun 19, 2014, 04:47 PM |
Sheridan William P | Senior VP - CMO | Jun 03, 2014 | Option Exercise | $9.86 | 10,177 | 100,345 | 148,173 | Jun 05, 2014, 02:15 PM |
Sheridan William P | Senior VP - CMO | Jun 03, 2014 | Option Exercise | $4.73 | 21,228 | 100,333 | 150,872 | Jun 05, 2014, 02:15 PM |
STAAB THOMAS R II | Senior Vice President and CFO | May 22, 2014 | Option Exercise | $3.78 | 17,685 | 66,849 | 144,301 | May 27, 2014, 04:03 PM |
Stonehouse Jon P | President & CEO | May 09, 2014 | Option Exercise | $7.70 | 30,214 | 232,648 | 640,445 | May 12, 2014, 03:38 PM |
Stonehouse Jon P | President & CEO | May 09, 2014 | Option Exercise | $5.76 | 40,417 | 232,635 | 659,424 | May 12, 2014, 03:38 PM |
ABERCROMBIE GEORGE B | Director | Mar 31, 2014 | Option Exercise | $1.71 | 4,000 | 6,840 | 10,000 | Apr 01, 2014, 10:37 AM |
STAAB THOMAS R II | Senior Vice President and CFO | Mar 14, 2014 | Option Exercise | $4.73 | 3,125 | 14,781 | 129,741 | Mar 17, 2014, 02:52 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Mar 14, 2014 | Sale | $11.24 | 3,125 | 35,125 | 126,616 | Mar 17, 2014, 02:52 PM |
LEE KENNETH B JR | Director | Mar 06, 2014 | Option Exercise | $3.80 | 22,917 | 87,085 | 22,917 | Mar 07, 2014, 04:17 PM |
LEE KENNETH B JR | Director | Mar 06, 2014 | Sale | $12.69 | 12,665 | 160,719 | 10,252 | Mar 07, 2014, 04:17 PM |
Babu Yarlagadda S | Senior VP - Drug Discovery | Mar 01, 2014 | Option Exercise | $11.69 | 1,618 | 18,914 | 220,021 | Mar 07, 2014, 04:14 PM |
Babu Yarlagadda S | Senior VP - Drug Discovery | Mar 04, 2014 | Option Exercise | $8.37 | 28,816 | 241,177 | 248,837 | Mar 07, 2014, 04:14 PM |
Babu Yarlagadda S | Senior VP - Drug Discovery | Mar 04, 2014 | Sale | $12.57 | 40,642 | 510,870 | 208,195 | Mar 07, 2014, 04:14 PM |
Barnes Alane P | VP, General Counsel & Corp Sec | Mar 01, 2014 | Option Exercise | $11.69 | 1,090 | 12,742 | 81,182 | Mar 07, 2014, 04:11 PM |
Barnes Alane P | VP, General Counsel & Corp Sec | Mar 04, 2014 | Option Exercise | $4.01 | 31,174 | 124,897 | 112,356 | Mar 07, 2014, 04:11 PM |
Barnes Alane P | VP, General Counsel & Corp Sec | Mar 04, 2014 | Sale | $12.63 | 40,734 | 514,470 | 71,622 | Mar 07, 2014, 04:11 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Mar 01, 2014 | Option Exercise | $11.69 | 461 | 5,389 | 126,616 | Mar 07, 2014, 04:02 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Mar 04, 2014 | Option Exercise | $4.73 | 3,000 | 14,190 | 129,616 | Mar 07, 2014, 04:02 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Mar 04, 2014 | Sale | $12.69 | 3,000 | 38,070 | 126,616 | Mar 07, 2014, 04:02 PM |
Stonehouse Jon P | President & CEO | Mar 01, 2014 | Option Exercise | $11.69 | 5,118 | 59,829 | 630,242 | Mar 07, 2014, 03:59 PM |
Sheridan William P | Senior VP - CMO | Mar 01, 2014 | Option Exercise | $11.69 | 1,739 | 20,329 | 137,122 | Mar 07, 2014, 03:56 PM |
Babu Yarlagadda S | Senior VP - Drug Discovery | Feb 24, 2014 | Option Exercise | $12.20 | 8,170 | 99,674 | 221,639 | Feb 25, 2014, 02:34 PM |
Babu Yarlagadda S | Senior VP - Drug Discovery | Feb 24, 2014 | Option Exercise | $4.30 | 23,179 | 99,670 | 229,809 | Feb 25, 2014, 02:34 PM |
Barnes Alane P | VP, General Counsel & Corp Sec | Jan 14, 2014 | Option Exercise | $10.87 | 1,491 | 16,207 | 54,487 | Jan 15, 2014, 08:55 AM |
Barnes Alane P | VP, General Counsel & Corp Sec | Jan 14, 2014 | Option Exercise | $1.20 | 13,500 | 16,200 | 55,978 | Jan 15, 2014, 08:55 AM |
STAAB THOMAS R II | Senior Vice President and CFO | Jan 13, 2014 | Option Exercise | $10.55 | 12,621 | 133,152 | 72,218 | Jan 15, 2014, 08:51 AM |
STAAB THOMAS R II | Senior Vice President and CFO | Jan 13, 2014 | Option Exercise | $3.78 | 35,225 | 133,150 | 84,839 | Jan 15, 2014, 08:51 AM |
Stonehouse Jon P | President & CEO | Jan 01, 2014 | Option Exercise | $7.60 | 8,592 | 65,299 | 504,360 | Jan 03, 2014, 03:59 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Jan 01, 2014 | Option Exercise | $7.60 | 2,453 | 18,643 | 49,614 | Jan 03, 2014, 03:56 PM |
Sheridan William P | SR VP - CMO | Jan 01, 2014 | Option Exercise | $7.60 | 2,735 | 20,786 | 82,539 | Jan 03, 2014, 03:55 PM |
Barnes Alane P | VP, General Counsel & Corp Sec | Jan 01, 2014 | Option Exercise | $7.60 | 2,453 | 18,643 | 42,478 | Jan 03, 2014, 03:52 PM |
Babu Yarlagadda S | VP Drug Discovery | Jan 01, 2014 | Option Exercise | $7.60 | 2,402 | 18,255 | 152,630 | Jan 03, 2014, 03:51 PM |
ABERCROMBIE GEORGE B | Director | Nov 12, 2013 | Buy | $6.19 | 3,000 | 18,570 | 6,000 | Nov 13, 2013, 04:25 PM |
BAKER FELIX | 10% Owner | Aug 01, 2013 | Buy | $4.40 | 1,136,364 | 5,000,002 | 4,832,285 | Aug 02, 2013, 04:00 PM |
Sheridan William P | SR VP - CMO | May 28, 2013 | Option Exercise | $1.20 | 16,407 | 19,688 | 82,274 | May 29, 2013, 04:00 PM |
Stonehouse Jon P | President & CEO | May 23, 2013 | Option Exercise | $1.20 | 179,600 | 215,520 | 509,952 | May 28, 2013, 01:55 PM |
Stonehouse Jon P | President & CEO | Jan 31, 2013 | Option Exercise | $1.38 | 3,000 | 4,140 | 340,225 | Mar 14, 2013, 04:34 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Jan 31, 2013 | Option Exercise | $1.38 | 2,745 | 3,788 | 52,609 | Mar 14, 2013, 04:32 PM |
Sheridan William P | SR VP - CMO | Jan 31, 2013 | Option Exercise | $1.38 | 3,000 | 4,140 | 67,656 | Mar 14, 2013, 04:30 PM |
ABERCROMBIE GEORGE B | Director | Mar 05, 2013 | Buy | $1.23 | 3,000 | 3,690 | 3,000 | Mar 06, 2013, 04:45 PM |
Sheridan William P | SR VP - CMO | Mar 01, 2013 | Option Exercise | $1.19 | 1,789 | 2,129 | 62,867 | Mar 06, 2013, 04:44 PM |
Babu Yarlagadda S | VP Drug Discovery | Mar 01, 2013 | Option Exercise | $1.19 | 1,903 | 2,265 | 155,032 | Mar 06, 2013, 04:42 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Mar 01, 2013 | Option Exercise | $1.19 | 542 | 645 | 49,322 | Mar 06, 2013, 04:41 PM |
Stonehouse Jon P | President & CEO | Mar 01, 2013 | Option Exercise | $1.19 | 5,967 | 7,101 | 331,258 | Mar 06, 2013, 04:38 PM |
Jensen Peder | Director | Dec 14, 2012 | Buy | $1.51 | 20,000 | 30,200 | 60,000 | Dec 17, 2012, 12:10 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Jul 01, 2012 | Option Exercise | $3.97 | 8,113 | 32,209 | 31,617 | Jul 02, 2012, 02:49 PM |
Jensen Peder | Director | Jun 05, 2012 | Buy | $3.18 | 20,000 | 63,680 | 40,000 | Jun 05, 2012, 07:38 PM |
Stonehouse Jon P | President & CEO | Mar 15, 2012 | Option Exercise | $5.23 | 13,612 | 71,191 | 267,719 | Mar 19, 2012, 04:11 PM |
STAAB THOMAS R II | Senior Vice President and CFO | Mar 15, 2012 | Option Exercise | $5.23 | 4,162 | 21,767 | 37,124 | Mar 19, 2012, 04:07 PM |
McCullough David | VP | Mar 15, 2012 | Option Exercise | $5.23 | 5,307 | 27,756 | 24,124 | Mar 19, 2012, 01:12 PM |
LOWREY ROBERT S | Controller, PAO | Mar 15, 2012 | Option Exercise | $5.23 | 2,686 | 14,048 | 9,766 | Mar 19, 2012, 01:10 PM |
Babu Yarlagadda S | VP Drug Discovery | Mar 15, 2012 | Option Exercise | $5.23 | 6,872 | 35,941 | 139,935 | Mar 19, 2012, 12:19 PM |
Sheridan William P | SR VP - CMO | Mar 15, 2012 | Option Exercise | $5.23 | 7,543 | 39,450 | 44,656 | Mar 19, 2012, 11:48 AM |
SANDERS CHARLES A | Director | Mar 13, 2012 | Buy | $5.20 | 2,000 | 10,400 | 7,000 | Mar 15, 2012, 03:21 PM |
SANDERS CHARLES A | Director | Mar 13, 2012 | Buy | $5.22 | 2,000 | 10,430 | 7,000 | Mar 15, 2012, 12:21 PM |
Stonehouse Jon P | President & CEO | Mar 02, 2012 | Sale | $4.78 | 2,721 | 13,006 | 239,384 | Mar 05, 2012, 05:09 PM |
Sheridan William P | SR VP - CMO | Mar 02, 2012 | Sale | $4.78 | 956 | 4,570 | 29,330 | Mar 05, 2012, 03:38 PM |
McCullough David | VP | Mar 02, 2012 | Sale | $4.78 | 574 | 2,744 | 13,926 | Mar 05, 2012, 02:58 PM |
Babu Yarlagadda S | VP Drug Discovery | Mar 02, 2012 | Sale | $4.78 | 837 | 4,001 | 125,769 | Mar 05, 2012, 02:30 PM |
Babu Yarlagadda S | VP Drug Discovery | Feb 22, 2012 | Option Exercise | $1.19 | 30,912 | 36,781 | 83,650 | Feb 23, 2012, 04:40 PM |
Babu Yarlagadda S | VP Drug Discovery | Feb 22, 2012 | Sale | $4.22 | 30,912 | 130,449 | 52,738 | Feb 23, 2012, 04:40 PM |
McCullough David | VP | Jan 03, 2012 | Option Exercise | $1.20 | 60,624 | 72,749 | 66,624 | Jan 05, 2012, 01:47 PM |
McCullough David | VP | Jan 03, 2012 | Sale | $2.45 | 60,624 | 148,529 | 6,000 | Jan 05, 2012, 01:47 PM |
McCullough David | VP | Dec 07, 2011 | Sale | $2.85 | 4,542 | 12,945 | 6,000 | Dec 08, 2011, 02:41 PM |
Jensen Peder | Director | Nov 18, 2011 | Buy | $2.75 | 10,000 | 27,500 | 20,000 | Nov 18, 2011, 02:52 PM |
Stonehouse Jon P | President & CEO | Aug 08, 2011 | Buy | $2.52 | 10,000 | 25,190 | 217,492 | Aug 09, 2011, 01:55 PM |
Jensen Peder | Director | May 12, 2011 | Buy | $3.56 | 10,000 | 35,600 | 10,000 | May 16, 2011, 06:01 PM |
Grant Stuart | SR VP & CFO | Mar 16, 2011 | Option Exercise | $1.20 | 65,000 | 78,000 | 63,102 | Mar 18, 2011, 04:49 PM |
Grant Stuart | SR VP & CFO | Mar 16, 2011 | Sale | $3.39 | 22,615 | 76,725 | 57,102 | Mar 18, 2011, 04:49 PM |
Stonehouse Jon P | President & CEO | Mar 18, 2011 | Buy | $3.40 | 10,000 | 33,988 | 194,180 | Mar 18, 2011, 04:25 PM |
Grant Stuart | SR VP & CFO | Aug 04, 2010 | Option Exercise | $1.20 | 2,500 | 3,000 | 14,217 | Aug 06, 2010, 12:42 PM |
Grant Stuart | SR VP & CFO | Aug 04, 2010 | Sale | $6.20 | 2,500 | 15,500 | 11,717 | Aug 06, 2010, 12:42 PM |
Owner | Relationship | Date | Value($) |
MILANO VINCENT | Director | 11/30/2023 | 5,621 |
HEGGIE THERESA | Director | 11/30/2023 | 5,621 |
MILANO VINCENT | Director | 08/31/2023 | 5,624 |
HEGGIE THERESA | Director | 08/31/2023 | 5,624 |
SANDERS MACHELLE | Director | 06/15/2023 | 31,920 |
Hutson Nancy J | Director | 06/14/2023 | 103,443 |
MILANO VINCENT | Director | 05/31/2023 | 5,624 |
LEVIN ALAN G | Director | 05/31/2023 | 11,247 |
HEGGIE THERESA | Director | 05/31/2023 | 5,624 |
Thackray Helen M. | Chief R&D Officer | 04/03/2023 | 58,030 |
Stonehouse Jon P | President & CEO | 03/21/2023 | 99,997 |
MILANO VINCENT | Director | 02/28/2023 | 5,620 |
INGRAM ROBERT ALEXANDER | Director | 02/28/2023 | 19,992 |
Stonehouse Jon P | President & CEO | 02/01/2023 | 545,000 |
Stonehouse Jon P | President & CEO | 02/01/2023 | 1,038,000 |
LEE KENNETH B JR | Director | 01/31/2023 | 25,650 |
Stonehouse Jon P | President & CEO | 12/15/2022 | 153,690 |
Thackray Helen M. | Chief R&D Officer | 12/15/2022 | 34,031 |
Doyle Anthony | Chief Financial Officer | 12/15/2022 | 62,130 |
Gayer Charles K | Chief Commercial Officer | 12/15/2022 | 66,490 |
Jones Michael L | Exec. Director, Finance - PAO | 12/15/2022 | 4,850 |
Barnes Alane P | Chief Legal Officer | 12/15/2022 | 45,424 |
Jones Michael L | Exec. Director, Finance - PAO | 12/01/2022 | 12,212 |
Jones Michael L | Exec. Director, Finance - PAO | 12/01/2022 | 111,886 |
Stonehouse Jon P | President & CEO | 12/02/2022 | 117,372 |
Stonehouse Jon P | President & CEO | 12/01/2022 | 305,182 |
Stonehouse Jon P | President & CEO | 12/02/2022 | 1,057,997 |
Stonehouse Jon P | President & CEO | 12/01/2022 | 2,793,921 |
HEGGIE THERESA | Director | 11/30/2022 | 5,625 |
MILANO VINCENT | Director | 11/30/2022 | 5,625 |
LEVIN ALAN G | Director | 11/30/2022 | 11,249 |
INGRAM ROBERT ALEXANDER | Director | 11/30/2022 | 20,000 |
Babu Yarlagadda S | Chief Discovery Officer | 11/14/2022 | 142,000 |
Babu Yarlagadda S | Chief Discovery Officer | 11/14/2022 | 437,428 |
MILANO VINCENT | Director | 08/31/2022 | 5,616 |
LEVIN ALAN G | Director | 08/31/2022 | 11,245 |
INGRAM ROBERT ALEXANDER | Director | 08/31/2022 | 19,988 |
HEGGIE THERESA | Director | 08/31/2022 | 5,616 |
ASELAGE STEVE | Director | 05/31/2022 | 5,297 |
HEGGIE THERESA | Director | 05/31/2022 | 10,595 |
LEVIN ALAN G | Director | 05/31/2022 | 10,595 |
INGRAM ROBERT ALEXANDER | Director | 05/31/2022 | 19,346 |
ABERCROMBIE GEORGE B | Director | 04/18/2022 | 16,600 |
ABERCROMBIE GEORGE B | Director | 04/18/2022 | 55,200 |
Thackray Helen M. | Chief R&D Officer | 04/01/2022 | 123,120 |
Sheridan William P | Chief Medical Officer | 03/10/2022 | 477,532 |
Sheridan William P | Chief Medical Officer | 03/10/2022 | 2,719,493 |
Babu Yarlagadda S | Chief Discovery Officer | 03/07/2022 | 343,200 |
Jones Michael L | Exec. Director, Finance - PAO | 03/01/2022 | 10,879 |
Jones Michael L | Exec. Director, Finance - PAO | 03/01/2022 | 39,560 |
LEVIN ALAN G | Director | 02/28/2022 | 9,999 |
INGRAM ROBERT ALEXANDER | Director | 02/28/2022 | 18,736 |
ABERCROMBIE GEORGE B | Director | 02/15/2022 | 16,600 |
ABERCROMBIE GEORGE B | Director | 02/15/2022 | 92,500 |
Stonehouse Jon P | President & CEO | 01/11/2022 | 870,320 |
Stonehouse Jon P | President & CEO | 01/11/2022 | 2,767,360 |
Babu Yarlagadda S | Chief Discovery Officer | 12/07/2021 | 293,260 |
Babu Yarlagadda S | Chief Discovery Officer | 12/07/2021 | 367,220 |
ASELAGE STEVE | Director | 11/30/2021 | 4,993 |
LEVIN ALAN G | Director | 11/30/2021 | 9,998 |
HEGGIE THERESA | Director | 11/30/2021 | 9,998 |
INGRAM ROBERT ALEXANDER | Director | 11/30/2021 | 18,741 |
MILANO VINCENT | Director | 11/24/2021 | 91,425 |
Doyle Anthony | Chief Financial Officer | 11/23/2021 | 440,020 |
ABERCROMBIE GEORGE B | Director | 11/15/2021 | 16,600 |
ABERCROMBIE GEORGE B | Director | 11/15/2021 | 61,350 |
Hutson Nancy J | Director | 10/15/2021 | 363,450 |
Hutson Nancy J | Director | 10/15/2021 | 1,617,000 |
ABERCROMBIE GEORGE B | Director | 09/15/2021 | 13,150 |
ABERCROMBIE GEORGE B | Director | 09/15/2021 | 75,300 |
LEE KENNETH B JR | Director | 09/13/2021 | 48,300 |
LEE KENNETH B JR | Director | 09/13/2021 | 92,100 |
ABERCROMBIE GEORGE B | Director | 09/10/2021 | 202,710 |
ABERCROMBIE GEORGE B | Director | 09/10/2021 | 1,116,660 |
LEVIN ALAN G | Director | 08/31/2021 | 9,998 |
INGRAM ROBERT ALEXANDER | Director | 08/31/2021 | 18,738 |
HEGGIE THERESA | Director | 08/31/2021 | 9,998 |
ASELAGE STEVE | Director | 08/31/2021 | 4,999 |
ABERCROMBIE GEORGE B | Director | 07/15/2021 | 13,150 |
ABERCROMBIE GEORGE B | Director | 07/15/2021 | 78,450 |
Hutson Nancy J | Director | 05/28/2021 | 4,999 |
ASELAGE STEVE | Director | 05/28/2021 | 9,998 |
Barnes Alane P | Chief Legal Officer | 05/12/2021 | 169,580 |
Barnes Alane P | Chief Legal Officer | 05/11/2021 | 425,442 |
Barnes Alane P | Chief Legal Officer | 05/11/2021 | 1,237,471 |
ABERCROMBIE GEORGE B | Director | 05/10/2021 | 88,900 |
Jones Michael L | Exec. Director, Finance - PAO | 03/18/2021 | 15,795 |
INGRAM ROBERT ALEXANDER | Director | 02/26/2021 | 18,746 |
Hutson Nancy J | Director | 02/26/2021 | 4,991 |
HEGGIE THERESA | Director | 02/26/2021 | 4,991 |
ASELAGE STEVE | Director | 02/26/2021 | 9,993 |
Sheridan William P | Senior VP - CMO | 02/22/2021 | 171,188 |
Sheridan William P | Senior VP - CMO | 02/22/2021 | 477,262 |
Babu Yarlagadda S | Senior VP - Drug Discovery | 02/19/2021 | 258,629 |
Babu Yarlagadda S | Senior VP - Drug Discovery | 02/19/2021 | 207,500 |
Stonehouse Jon P | President & CEO | 12/15/2020 | 557,254 |
Stonehouse Jon P | President & CEO | 12/15/2020 | 1,117,193 |
Barnes Alane P | Senior VP, Chief Legal Officer | 12/11/2020 | 57,025 |
Barnes Alane P | Senior VP, Chief Legal Officer | 12/11/2020 | 109,378 |
Barnes Alane P | Senior VP, Chief Legal Officer | 12/04/2020 | 57,025 |
Barnes Alane P | Senior VP, Chief Legal Officer | 12/04/2020 | 85,606 |
HEGGIE THERESA | Director | 11/30/2020 | 4,998 |
ASELAGE STEVE | Director | 11/30/2020 | 9,995 |
Hutson Nancy J | Director | 11/30/2020 | 4,998 |
INGRAM ROBERT ALEXANDER | Director | 11/30/2020 | 18,749 |
Hutson Nancy J | Director | 08/31/2020 | 4,997 |
HEGGIE THERESA | Director | 08/31/2020 | 4,997 |
ASELAGE STEVE | Director | 08/31/2020 | 9,997 |
INGRAM ROBERT ALEXANDER | Director | 08/31/2020 | 18,750 |
Doyle Anthony | Chief Financial Officer | 08/11/2020 | 220,320 |
ASELAGE STEVE | Director | 06/01/2020 | 4,998 |
HEGGIE THERESA | Director | 06/01/2020 | 4,998 |
Hutson Nancy J | Director | 06/01/2020 | 9,997 |
INGRAM ROBERT ALEXANDER | Director | 06/01/2020 | 18,749 |
Hutson Nancy J | Director | 03/01/2020 | 9,999 |
INGRAM ROBERT ALEXANDER | Director | 03/01/2020 | 18,750 |
HEGGIE THERESA | Director | 03/01/2020 | 4,998 |
ASELAGE STEVE | Director | 03/01/2020 | 4,998 |
HEGGIE THERESA | Director | 12/01/2019 | 4,999 |
ASELAGE STEVE | Director | 12/01/2019 | 4,999 |
Hutson Nancy J | Director | 12/01/2019 | 9,998 |
INGRAM ROBERT ALEXANDER | Director | 12/01/2019 | 18,747 |
Stonehouse Jon P | President & CEO | 11/18/2019 | 72,500 |
Sniecinski Megan | Chief Business Officer | 11/18/2019 | 65,250 |
LEE KENNETH B JR | Director | 11/18/2019 | 7,250 |
INGRAM ROBERT ALEXANDER | Director | 11/18/2019 | 29,000 |
Hutson Nancy J | Director | 11/18/2019 | 14,500 |
HEGGIE THERESA | Director | 11/18/2019 | 7,250 |
Barnes Alane P | Senior VP, Chief Legal Officer | 11/18/2019 | 29,000 |
Babu Yarlagadda S | Senior VP - Drug Discovery | 11/18/2019 | 36,250 |
ASELAGE STEVE | Director | 11/18/2019 | 21,750 |
HEGGIE THERESA | Director | 09/01/2019 | 4,999 |
ASELAGE STEVE | Director | 09/01/2019 | 4,999 |
Hutson Nancy J | Director | 09/01/2019 | 9,999 |
INGRAM ROBERT ALEXANDER | Director | 09/01/2019 | 18,747 |
ASELAGE STEVE | Director | 05/22/2019 | 10,710 |
STAAB THOMAS R II | Senior Vice President and CFO | 05/16/2019 | 6,745 |
STAAB THOMAS R II | Senior Vice President and CFO | 05/17/2019 | 18,625 |
STAAB THOMAS R II | Senior Vice President and CFO | 05/16/2019 | 55,970 |
STAAB THOMAS R II | Senior Vice President and CFO | 05/15/2019 | 6,745 |
STAAB THOMAS R II | Senior Vice President and CFO | 05/14/2019 | 6,390 |
STAAB THOMAS R II | Senior Vice President and CFO | 05/15/2019 | 57,420 |
STAAB THOMAS R II | Senior Vice President and CFO | 05/14/2019 | 34,290 |
STAAB THOMAS R II | Senior Vice President and CFO | 05/09/2019 | 53,723 |
STAAB THOMAS R II | Senior Vice President and CFO | 05/13/2019 | 53,723 |
STAAB THOMAS R II | Senior Vice President and CFO | 05/09/2019 | 74,393 |
STAAB THOMAS R II | Senior Vice President and CFO | 05/13/2019 | 75,660 |
STAAB THOMAS R II | Senior Vice President and CFO | 05/06/2019 | 49,590 |
STAAB THOMAS R II | Senior Vice President and CFO | 05/02/2019 | 42,703 |
STAAB THOMAS R II | Senior Vice President and CFO | 05/06/2019 | 69,750 |
STAAB THOMAS R II | Senior Vice President and CFO | 05/02/2019 | 56,575 |
STAAB THOMAS R II | Senior Vice President and CFO | 04/04/2019 | 41,325 |
STAAB THOMAS R II | Senior Vice President and CFO | 04/04/2019 | 66,075 |
ASELAGE STEVE | Director | 03/12/2019 | 16,600 |
Babu Yarlagadda S | Senior VP - Drug Discovery | 01/31/2019 | 81,479 |
Babu Yarlagadda S | Senior VP - Drug Discovery | 01/31/2019 | 38,249 |
STAAB THOMAS R II | Senior Vice President and CFO | 01/28/2019 | 27,250 |
STAAB THOMAS R II | Senior Vice President and CFO | 01/28/2019 | 49,250 |
Powell Lynne | Senior VP - CCO | 01/28/2019 | 19,320 |
Powell Lynne | Senior VP - CCO | 01/25/2019 | 19,320 |
Powell Lynne | Senior VP - CCO | 01/28/2019 | 59,340 |
Powell Lynne | Senior VP - CCO | 01/25/2019 | 57,600 |
Powell Lynne | Senior VP - CCO | 01/18/2019 | 6,440 |
Powell Lynne | Senior VP - CCO | 01/18/2019 | 18,800 |
Powell Lynne | Senior VP - CCO | 01/16/2019 | 9,808 |
Powell Lynne | Senior VP - CCO | 01/16/2019 | 28,236 |
Powell Lynne | Senior VP - CCO | 01/14/2019 | 3,072 |
Powell Lynne | Senior VP - CCO | 01/14/2019 | 8,777 |
STAAB THOMAS R II | Senior Vice President and CFO | 01/01/2019 | 6,335 |
Stonehouse Jon P | President & CEO | 01/01/2019 | 28,794 |
Babu Yarlagadda S | Senior VP - Drug Discovery | 01/01/2019 | 6,222 |
Barnes Alane P | Senior VP, Chief Legal Officer | 01/01/2019 | 3,414 |
Sheridan William P | Senior VP - CMO | 01/01/2019 | 8,772 |
Sheridan William P | Senior VP - CMO | 12/18/2018 | 155,299 |
Powell Lynne | Senior VP - CCO | 12/10/2018 | 12,880 |
Powell Lynne | Senior VP - CCO | 12/10/2018 | 36,240 |
Stonehouse Jon P | President & CEO | 12/03/2018 | 96,000 |
Stonehouse Jon P | President & CEO | 12/03/2018 | 729,600 |
STAAB THOMAS R II | Senior Vice President and CFO | 12/04/2018 | 37,063 |
Barnes Alane P | Senior VP, Chief Legal Officer | 11/30/2018 | 35,500 |
Barnes Alane P | Senior VP, Chief Legal Officer | 11/30/2018 | 401,710 |
Erck Stanley C | Director | 11/28/2018 | 12,416 |
Powell Lynne | Senior VP - CCO | 11/21/2018 | 38,640 |
Powell Lynne | Senior VP - CCO | 11/21/2018 | 130,840 |
STAAB THOMAS R II | Senior Vice President and CFO | 11/23/2018 | 13,230 |
STAAB THOMAS R II | Senior Vice President and CFO | 11/21/2018 | 53,710 |
STAAB THOMAS R II | Senior Vice President and CFO | 11/23/2018 | 33,810 |
STAAB THOMAS R II | Senior Vice President and CFO | 11/21/2018 | 110,610 |
Powell Lynne | Senior VP - CCO | 11/19/2018 | 621 |
Powell Lynne | Senior VP - CCO | 11/20/2018 | 29,389 |
Powell Lynne | Senior VP - CCO | 11/19/2018 | 1,602 |
Powell Lynne | Senior VP - CCO | 11/20/2018 | 130,714 |
STAAB THOMAS R II | Senior Vice President and CFO | 11/20/2018 | 38,405 |
STAAB THOMAS R II | Senior Vice President and CFO | 11/19/2018 | 283 |
STAAB THOMAS R II | Senior Vice President and CFO | 11/20/2018 | 96,494 |
STAAB THOMAS R II | Senior Vice President and CFO | 11/19/2018 | 623 |
STAAB THOMAS R II | Senior Vice President and CFO | 11/08/2018 | 44,485 |
STAAB THOMAS R II | Senior Vice President and CFO | 11/07/2018 | 2,164 |
STAAB THOMAS R II | Senior Vice President and CFO | 11/07/2018 | 5,376 |
STAAB THOMAS R II | Senior Vice President and CFO | 11/08/2018 | 109,011 |
Powell Lynne | Senior VP - CCO | 11/07/2018 | 966 |
Powell Lynne | Senior VP - CCO | 11/08/2018 | 17,002 |
Powell Lynne | Senior VP - CCO | 11/08/2018 | 43,032 |
Powell Lynne | Senior VP - CCO | 11/07/2018 | 2,400 |
Powell Lynne | Senior VP - CCO | 11/05/2018 | 322 |
Powell Lynne | Senior VP - CCO | 11/05/2018 | 800 |
STAAB THOMAS R II | Senior Vice President and CFO | 11/05/2018 | 692 |
STAAB THOMAS R II | Senior Vice President and CFO | 11/05/2018 | 1,720 |
Powell Lynne | Senior VP - CCO | 11/02/2018 | 3,220 |
Powell Lynne | Senior VP - CCO | 11/02/2018 | 8,000 |
STAAB THOMAS R II | Senior Vice President and CFO | 11/02/2018 | 36,916 |
STAAB THOMAS R II | Senior Vice President and CFO | 11/02/2018 | 85,090 |
Powell Lynne | Senior VP - CCO | 11/01/2018 | 11,595 |
STAAB THOMAS R II | Senior Vice President and CFO | 10/19/2018 | 11,907 |
STAAB THOMAS R II | Senior Vice President and CFO | 10/19/2018 | 23,467 |
Powell Lynne | Senior VP - CCO | 10/19/2018 | 750 |
STAAB THOMAS R II | Senior Vice President and CFO | 10/03/2018 | 3,508 |
STAAB THOMAS R II | Senior Vice President and CFO | 10/02/2018 | 30,085 |
STAAB THOMAS R II | Senior Vice President and CFO | 10/02/2018 | 63,556 |
STAAB THOMAS R II | Senior Vice President and CFO | 10/03/2018 | 7,802 |
Sheridan William P | Senior VP - CMO | 08/09/2018 | 88,750 |
Sheridan William P | Senior VP - CMO | 08/09/2018 | 439,375 |
Sheridan William P | Senior VP - CMO | 06/01/2018 | 108,649 |
Sheridan William P | Senior VP - CMO | 06/01/2018 | 265,306 |
INGRAM ROBERT ALEXANDER | Director | 06/01/2018 | 18,750 |
Hutson Nancy J | Director | 06/01/2018 | 9,999 |
Stonehouse Jon P | President & CEO | 05/17/2018 | 100,006 |
Barnes Alane P | VP, General Counsel & Corp Sec | 05/15/2018 | 17,754 |
Barnes Alane P | VP, General Counsel & Corp Sec | 05/15/2018 | 17,750 |
Babu Yarlagadda S | Senior VP - Drug Discovery | 03/06/2018 | 109,427 |
Babu Yarlagadda S | Senior VP - Drug Discovery | 03/06/2018 | 97,800 |
Stonehouse Jon P | President & CEO | 02/28/2018 | 214,823 |
Stonehouse Jon P | President & CEO | 02/28/2018 | 185,654 |
Barnes Alane P | VP, General Counsel & Corp Sec | 02/28/2018 | 21,871 |
INGRAM ROBERT ALEXANDER | Director | 03/01/2018 | 18,747 |
Hutson Nancy J | Director | 03/01/2018 | 10,000 |
Barnes Alane P | VP, General Counsel & Corp Sec | 01/20/2018 | 10,962 |
Babu Yarlagadda S | Senior VP - Drug Discovery | 01/20/2018 | 21,644 |
Sheridan William P | Senior VP - CMO | 01/20/2018 | 25,871 |
STAAB THOMAS R II | Senior Vice President and CFO | 01/20/2018 | 22,243 |
Stonehouse Jon P | President & CEO | 01/20/2018 | 53,575 |
Barnes Alane P | VP, General Counsel & Corp Sec | 01/01/2018 | 2,254 |
Babu Yarlagadda S | Senior VP - Drug Discovery | 01/01/2018 | 4,115 |
Sheridan William P | Senior VP - CMO | 01/01/2018 | 5,740 |
STAAB THOMAS R II | Senior Vice President and CFO | 01/01/2018 | 4,183 |
Stonehouse Jon P | President & CEO | 01/01/2018 | 13,336 |
INGRAM ROBERT ALEXANDER | Director | 12/01/2017 | 18,745 |
Hutson Nancy J | Director | 12/01/2017 | 9,997 |
Sheridan William P | Senior VP - CMO | 11/13/2017 | 303,543 |
Cohen Fred E | Director | 09/18/2017 | 231,647 |
Cohen Fred E | Director | 09/18/2017 | 294,035 |
INGRAM ROBERT ALEXANDER | Director | 09/01/2017 | 18,748 |
Hutson Nancy J | Director | 09/01/2017 | 9,996 |
INGRAM ROBERT ALEXANDER | Director | 06/01/2017 | 9,996 |
Hutson Nancy J | Director | 06/01/2017 | 9,996 |
Cohen Fred E | Director | 06/01/2017 | 9,996 |
STAAB THOMAS R II | Senior Vice President and CFO | 05/22/2017 | 36,659 |
STAAB THOMAS R II | Senior Vice President and CFO | 05/22/2017 | 36,658 |
STAAB THOMAS R II | Senior Vice President and CFO | 03/20/2017 | 12,285 |
STAAB THOMAS R II | Senior Vice President and CFO | 03/20/2017 | 29,900 |
STAAB THOMAS R II | Senior Vice President and CFO | 03/16/2017 | 108,310 |
STAAB THOMAS R II | Senior Vice President and CFO | 03/16/2017 | 108,300 |
STAAB THOMAS R II | Senior Vice President and CFO | 03/10/2017 | 12,285 |
STAAB THOMAS R II | Senior Vice President and CFO | 03/10/2017 | 29,445 |
STAAB THOMAS R II | Senior Vice President and CFO | 03/08/2017 | 24,570 |
STAAB THOMAS R II | Senior Vice President and CFO | 03/08/2017 | 54,762 |
STAAB THOMAS R II | Senior Vice President and CFO | 03/06/2017 | 12,285 |
STAAB THOMAS R II | Senior Vice President and CFO | 03/06/2017 | 25,675 |
INGRAM ROBERT ALEXANDER | Director | 03/02/2017 | 9,996 |
Hutson Nancy J | Director | 03/01/2017 | 9,996 |
Cohen Fred E | Director | 03/01/2017 | 9,996 |
Barnes Alane P | VP, General Counsel & Corp Sec | 01/20/2017 | 15,464 |
Babu Yarlagadda S | Senior VP - Drug Discovery | 01/20/2017 | 30,244 |
Sheridan William P | Senior VP - CMO | 01/20/2017 | 34,278 |
STAAB THOMAS R II | Senior Vice President and CFO | 01/20/2017 | 30,928 |
Stonehouse Jon P | President & CEO | 01/20/2017 | 62,903 |
Barnes Alane P | VP, General Counsel & Corp Sec | 01/01/2017 | 8,109 |
Babu Yarlagadda S | Senior VP - Drug Discovery | 01/01/2017 | 10,375 |
Sheridan William P | Senior VP - CMO | 01/01/2017 | 13,173 |
STAAB THOMAS R II | Senior Vice President and CFO | 01/01/2017 | 10,609 |
Stonehouse Jon P | President & CEO | 01/01/2017 | 54,406 |
STAAB THOMAS R II | Senior Vice President and CFO | 12/19/2016 | 12,285 |
STAAB THOMAS R II | Senior Vice President and CFO | 12/19/2016 | 24,212 |
INGRAM ROBERT ALEXANDER | Director | 12/01/2016 | 9,995 |
Hutson Nancy J | Director | 12/01/2016 | 9,995 |
Cohen Fred E | Director | 12/01/2016 | 9,995 |
Barnes Alane P | VP, General Counsel & Corp Sec | 09/14/2016 | 35,684 |
INGRAM ROBERT ALEXANDER | Director | 09/01/2016 | 10,000 |
Hutson Nancy J | Director | 09/01/2016 | 10,000 |
Cohen Fred E | Director | 09/01/2016 | 10,000 |
Babu Yarlagadda S | Senior VP - Drug Discovery | 08/25/2016 | 121,800 |
BAKER BROS. ADVISORS LP | 10% Owner | 08/16/2016 | 4,246 |
BAKER BROS. ADVISORS LP | 10% Owner | 08/15/2016 | 1,931,040 |
BAKER BROS. ADVISORS LP | 10% Owner | 08/12/2016 | 18,315,817 |
STAAB THOMAS R II | Senior Vice President and CFO | 08/12/2016 | 23,793 |
STAAB THOMAS R II | Senior Vice President and CFO | 08/11/2016 | 6,595 |
STAAB THOMAS R II | Senior Vice President and CFO | 08/09/2016 | 64,576 |
Hutson Nancy J | Director | 05/31/2016 | 8,750 |
Cohen Fred E | Director | 05/31/2016 | 8,750 |
Barnes Alane P | VP, General Counsel & Corp Sec | 03/01/2016 | 1,463 |
Babu Yarlagadda S | Senior VP - Drug Discovery | 03/01/2016 | 1,930 |
Sheridan William P | Senior VP - CMO | 03/01/2016 | 1,702 |
STAAB THOMAS R II | Senior Vice President and CFO | 03/01/2016 | 990 |
Stonehouse Jon P | President & CEO | 03/01/2016 | 5,881 |
SANDERS CHARLES A | Director | 02/29/2016 | 8,748 |
Hutson Nancy J | Director | 02/29/2016 | 8,748 |
Cohen Fred E | Director | 02/29/2016 | 8,748 |
BAKER BROS. ADVISORS LP | 10% Owner | 02/05/2016 | 284,656 |
BAKER BROS. ADVISORS LP | 10% Owner | 02/04/2016 | 164,915 |
BAKER BROS. ADVISORS LP | 10% Owner | 02/03/2016 | 573,311 |
BAKER BROS. ADVISORS LP | 10% Owner | 02/02/2016 | 598,360 |
Barnes Alane P | VP, General Counsel & Corp Sec | 01/29/2016 | 27,503 |
BAKER BROS. ADVISORS LP | 10% Owner | 01/27/2016 | 441,971 |
BAKER BROS. ADVISORS LP | 10% Owner | 01/28/2016 | 172,015 |
Powell Lynne | Senior VP - CCO | 01/26/2016 | 28,066 |
BAKER BROS. ADVISORS LP | 10% Owner | 01/22/2016 | 22,389 |
BAKER BROS. ADVISORS LP | 10% Owner | 01/21/2016 | 755,368 |
Barnes Alane P | VP, General Counsel & Corp Sec | 01/20/2016 | 19,622 |
Babu Yarlagadda S | Senior VP - Drug Discovery | 01/20/2016 | 35,666 |
Sheridan William P | Senior VP - CMO | 01/20/2016 | 40,460 |
STAAB THOMAS R II | Senior Vice President and CFO | 01/20/2016 | 36,414 |
Stonehouse Jon P | President & CEO | 01/20/2016 | 80,211 |
Stonehouse Jon P | President & CEO | 01/20/2016 | 99,998 |
STAAB THOMAS R II | Senior Vice President and CFO | 01/19/2016 | 27,200 |
BAKER BROS. ADVISORS LP | 10% Owner | 01/15/2016 | 1,491,222 |
BAKER BROS. ADVISORS LP | 10% Owner | 01/20/2016 | 362,171 |
BAKER BROS. ADVISORS LP | 10% Owner | 01/19/2016 | 656,750 |
Barnes Alane P | VP, General Counsel & Corp Sec | 01/01/2016 | 13,220 |
Babu Yarlagadda S | Senior VP - Drug Discovery | 01/01/2016 | 16,914 |
Sheridan William P | Senior VP - CMO | 01/01/2016 | 21,476 |
STAAB THOMAS R II | Senior Vice President and CFO | 01/01/2016 | 17,296 |
Stonehouse Jon P | President & CEO | 01/01/2016 | 83,499 |
STAAB THOMAS R II | Senior Vice President and CFO | 12/21/2015 | 33,145 |
STAAB THOMAS R II | Senior Vice President and CFO | 12/17/2015 | 31,470 |
SANDERS CHARLES A | Director | 11/30/2015 | 8,743 |
Hutson Nancy J | Director | 11/30/2015 | 8,743 |
Cohen Fred E | Director | 11/30/2015 | 8,743 |
SANDERS CHARLES A | Director | 08/31/2015 | 8,742 |
Hutson Nancy J | Director | 08/31/2015 | 8,742 |
Cohen Fred E | Director | 08/31/2015 | 8,742 |
STAAB THOMAS R II | Senior Vice President and CFO | 07/20/2015 | 57,750 |
Stonehouse Jon P | President & CEO | 07/15/2015 | 399,992 |
Stonehouse Jon P | President & CEO | 07/15/2015 | 399,981 |
STAAB THOMAS R II | Senior Vice President and CFO | 06/22/2015 | 17,738 |
STAAB THOMAS R II | Senior Vice President and CFO | 06/22/2015 | 60,000 |
Barnes Alane P | VP, General Counsel & Corp Sec | 06/19/2015 | 45,000 |
Sheridan William P | Senior VP - CMO | 06/19/2015 | 84,467 |
Sheridan William P | Senior VP - CMO | 06/19/2015 | 1,059,354 |
STAAB THOMAS R II | Senior Vice President and CFO | 06/19/2015 | 12,001 |
STAAB THOMAS R II | Senior Vice President and CFO | 06/18/2015 | 23,436 |
STAAB THOMAS R II | Senior Vice President and CFO | 06/19/2015 | 100,125 |
STAAB THOMAS R II | Senior Vice President and CFO | 06/18/2015 | 135,025 |
Stonehouse Jon P | President & CEO | 06/19/2015 | 24,000 |
Stonehouse Jon P | President & CEO | 06/19/2015 | 300,400 |
STAAB THOMAS R II | Senior Vice President and CFO | 06/05/2015 | 76,500 |
STAAB THOMAS R II | Senior Vice President and CFO | 06/01/2015 | 36,000 |
Cohen Fred E | Director | 05/29/2015 | 8,744 |
STAAB THOMAS R II | Senior Vice President and CFO | 05/18/2015 | 33,000 |
Babu Yarlagadda S | Senior VP - Drug Discovery | 03/19/2015 | 122,987 |
Babu Yarlagadda S | Senior VP - Drug Discovery | 03/05/2015 | 396,066 |
Babu Yarlagadda S | Senior VP - Drug Discovery | 03/04/2015 | 110,198 |
Barnes Alane P | VP, General Counsel & Corp Sec | 03/01/2015 | 11,424 |
Babu Yarlagadda S | Senior VP - Drug Discovery | 03/01/2015 | 16,667 |
Sheridan William P | Senior VP - CMO | 03/01/2015 | 17,738 |
STAAB THOMAS R II | Senior Vice President and CFO | 03/01/2015 | 4,743 |
Stonehouse Jon P | President & CEO | 03/01/2015 | 52,204 |
Cohen Fred E | Director | 02/27/2015 | 8,741 |
Hutson Nancy J | Director | 02/20/2015 | 102,700 |
Barnes Alane P | VP, General Counsel & Corp Sec | 01/20/2015 | 24,686 |
Babu Yarlagadda S | Senior VP - Drug Discovery | 01/20/2015 | 48,724 |
Sheridan William P | Senior VP - CMO | 01/20/2015 | 56,677 |
STAAB THOMAS R II | Senior Vice President and CFO | 01/20/2015 | 49,997 |
Stonehouse Jon P | President & CEO | 01/20/2015 | 118,491 |
Cohen Fred E | Director | 01/08/2015 | 129,000 |
Barnes Alane P | VP, General Counsel & Corp Sec | 01/01/2015 | 29,828 |
Babu Yarlagadda S | Senior VP - Drug Discovery | 01/01/2015 | 29,208 |
Sheridan William P | Senior VP - CMO | 01/01/2015 | 33,258 |
STAAB THOMAS R II | Senior Vice President and CFO | 01/01/2015 | 29,828 |
Stonehouse Jon P | President & CEO | 01/01/2015 | 68,728 |
Sheridan William P | Senior VP - CMO | 12/30/2014 | 32,808 |
Sheridan William P | Senior VP - CMO | 12/29/2014 | 205,742 |
Sheridan William P | Senior VP - CMO | 12/30/2014 | 278,634 |
Sheridan William P | Senior VP - CMO | 12/29/2014 | 1,308,817 |
STAAB THOMAS R II | Senior Vice President and CFO | 12/29/2014 | 35,910 |
STAAB THOMAS R II | Senior Vice President and CFO | 12/29/2014 | 119,320 |
Cohen Fred E | Director | 11/28/2014 | 8,745 |
Cohen Fred E | Director | 08/29/2014 | 8,748 |
STAAB THOMAS R II | Senior Vice President and CFO | 08/27/2014 | 54,500 |
STAAB THOMAS R II | Senior Vice President and CFO | 08/27/2014 | 135,800 |
STAAB THOMAS R II | Senior Vice President and CFO | 07/25/2014 | 100,007 |
STAAB THOMAS R II | Senior Vice President and CFO | 07/25/2014 | 100,000 |
STAAB THOMAS R II | Senior Vice President and CFO | 07/01/2014 | 14,781 |
STAAB THOMAS R II | Senior Vice President and CFO | 07/01/2014 | 40,625 |
STAAB THOMAS R II | Senior Vice President and CFO | 06/23/2014 | 14,781 |
STAAB THOMAS R II | Senior Vice President and CFO | 06/23/2014 | 39,031 |
STAAB THOMAS R II | Senior Vice President and CFO | 06/17/2014 | 14,781 |
STAAB THOMAS R II | Senior Vice President and CFO | 06/17/2014 | 37,500 |
Sheridan William P | Senior VP - CMO | 06/03/2014 | 100,345 |
Sheridan William P | Senior VP - CMO | 06/03/2014 | 100,333 |
STAAB THOMAS R II | Senior Vice President and CFO | 05/22/2014 | 66,849 |
Stonehouse Jon P | President & CEO | 05/09/2014 | 232,648 |
Stonehouse Jon P | President & CEO | 05/09/2014 | 232,635 |
ABERCROMBIE GEORGE B | Director | 03/31/2014 | 6,840 |
STAAB THOMAS R II | Senior Vice President and CFO | 03/14/2014 | 14,781 |
STAAB THOMAS R II | Senior Vice President and CFO | 03/14/2014 | 35,125 |
LEE KENNETH B JR | Director | 03/06/2014 | 87,085 |
LEE KENNETH B JR | Director | 03/06/2014 | 160,719 |
Babu Yarlagadda S | Senior VP - Drug Discovery | 03/01/2014 | 18,914 |
Babu Yarlagadda S | Senior VP - Drug Discovery | 03/04/2014 | 241,177 |
Babu Yarlagadda S | Senior VP - Drug Discovery | 03/04/2014 | 510,870 |
Barnes Alane P | VP, General Counsel & Corp Sec | 03/01/2014 | 12,742 |
Barnes Alane P | VP, General Counsel & Corp Sec | 03/04/2014 | 124,897 |
Barnes Alane P | VP, General Counsel & Corp Sec | 03/04/2014 | 514,470 |
STAAB THOMAS R II | Senior Vice President and CFO | 03/01/2014 | 5,389 |
STAAB THOMAS R II | Senior Vice President and CFO | 03/04/2014 | 14,190 |
STAAB THOMAS R II | Senior Vice President and CFO | 03/04/2014 | 38,070 |
Stonehouse Jon P | President & CEO | 03/01/2014 | 59,829 |
Sheridan William P | Senior VP - CMO | 03/01/2014 | 20,329 |
Babu Yarlagadda S | Senior VP - Drug Discovery | 02/24/2014 | 99,674 |
Babu Yarlagadda S | Senior VP - Drug Discovery | 02/24/2014 | 99,670 |
Barnes Alane P | VP, General Counsel & Corp Sec | 01/14/2014 | 16,207 |
Barnes Alane P | VP, General Counsel & Corp Sec | 01/14/2014 | 16,200 |
STAAB THOMAS R II | Senior Vice President and CFO | 01/13/2014 | 133,152 |
STAAB THOMAS R II | Senior Vice President and CFO | 01/13/2014 | 133,150 |
Stonehouse Jon P | President & CEO | 01/01/2014 | 65,299 |
STAAB THOMAS R II | Senior Vice President and CFO | 01/01/2014 | 18,643 |
Sheridan William P | SR VP - CMO | 01/01/2014 | 20,786 |
Barnes Alane P | VP, General Counsel & Corp Sec | 01/01/2014 | 18,643 |
Babu Yarlagadda S | VP Drug Discovery | 01/01/2014 | 18,255 |
ABERCROMBIE GEORGE B | Director | 11/12/2013 | 18,570 |
BAKER FELIX | 10% Owner | 08/01/2013 | 5,000,002 |
Sheridan William P | SR VP - CMO | 05/28/2013 | 19,688 |
Stonehouse Jon P | President & CEO | 05/23/2013 | 215,520 |
Stonehouse Jon P | President & CEO | 01/31/2013 | 4,140 |
STAAB THOMAS R II | Senior Vice President and CFO | 01/31/2013 | 3,788 |
Sheridan William P | SR VP - CMO | 01/31/2013 | 4,140 |
ABERCROMBIE GEORGE B | Director | 03/05/2013 | 3,690 |
Sheridan William P | SR VP - CMO | 03/01/2013 | 2,129 |
Babu Yarlagadda S | VP Drug Discovery | 03/01/2013 | 2,265 |
STAAB THOMAS R II | Senior Vice President and CFO | 03/01/2013 | 645 |
Stonehouse Jon P | President & CEO | 03/01/2013 | 7,101 |
Jensen Peder | Director | 12/14/2012 | 30,200 |
STAAB THOMAS R II | Senior Vice President and CFO | 07/01/2012 | 32,209 |
Jensen Peder | Director | 06/05/2012 | 63,680 |
Stonehouse Jon P | President & CEO | 03/15/2012 | 71,191 |
STAAB THOMAS R II | Senior Vice President and CFO | 03/15/2012 | 21,767 |
McCullough David | VP | 03/15/2012 | 27,756 |
LOWREY ROBERT S | Controller, PAO | 03/15/2012 | 14,048 |
Babu Yarlagadda S | VP Drug Discovery | 03/15/2012 | 35,941 |
Sheridan William P | SR VP - CMO | 03/15/2012 | 39,450 |
SANDERS CHARLES A | Director | 03/13/2012 | 10,400 |
SANDERS CHARLES A | Director | 03/13/2012 | 10,430 |
Stonehouse Jon P | President & CEO | 03/02/2012 | 13,006 |
Sheridan William P | SR VP - CMO | 03/02/2012 | 4,570 |
McCullough David | VP | 03/02/2012 | 2,744 |
Babu Yarlagadda S | VP Drug Discovery | 03/02/2012 | 4,001 |
Babu Yarlagadda S | VP Drug Discovery | 02/22/2012 | 36,781 |
Babu Yarlagadda S | VP Drug Discovery | 02/22/2012 | 130,449 |
McCullough David | VP | 01/03/2012 | 72,749 |
McCullough David | VP | 01/03/2012 | 148,529 |
McCullough David | VP | 12/07/2011 | 12,945 |
Jensen Peder | Director | 11/18/2011 | 27,500 |
Stonehouse Jon P | President & CEO | 08/08/2011 | 25,190 |
Jensen Peder | Director | 05/12/2011 | 35,600 |
Grant Stuart | SR VP & CFO | 03/16/2011 | 78,000 |
Grant Stuart | SR VP & CFO | 03/16/2011 | 76,725 |
Stonehouse Jon P | President & CEO | 03/18/2011 | 33,988 |
Grant Stuart | SR VP & CFO | 08/04/2010 | 3,000 |
Grant Stuart | SR VP & CFO | 08/04/2010 | 15,500 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BLACKROCK INC. | 16,774,304 | 0.00342% | 8.25% | Other |
BAKER BROS. ADVISORS LP | 12,710,818 | 0.52% | No change | Other |
FISHER ASSET MANAGEMENT, LLC | 3,185,199 | 0.01% | -26.35% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 3,911,077 | 0.0033% | 2.05% | Other |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,286,000 | 0.51% | 148.56% | Other |
BALYASNY ASSET MANAGEMENT L.P. | 408,297 | 0.0059% | New | Event Driven |
UBS OCONNOR LLC | 241,820 | 0.04% | 4.03% | Value |
RENAISSANCE TECHNOLOGIES LLC | 201,845 | 0.00244% | New | Other |
ALPS ADVISORS INC | 139,850 | 0.00822% | 0.7% | Other |
TUDOR INVESTMENT CORP ET AL | 94,435 | 0.0067% | 23.18% | Event Driven, Other |
AQR CAPITAL MANAGEMENT LLC | 73,517 | 0.00107% | 93.02% | Other |
GOTHAM ASSET MANAGEMENT, LLC | 69,033 | 0.01% | New | Other |
D. E. SHAW & CO., INC. | 10,403 | 0.00007% | Exited | Other |
Period of Report: 09/30/2023
10-K/10-Q Filings: View